Guidelines Establishing Test Procedures for the Analysis of Pollutants and National Primary Drinking Water Regulations; Flexibility in Existing Test Procedures and Streamlined Proposal of New Test Procedures

Federal RegisterMar 28, 1997

Ask Donna

What actually matters in this document.

Text

SUMMARY: The Environmental Protection Agency (EPA) proposes to

streamline the process for EPA approval of analytical methods (and

modifications thereof) under the Clean Water Act (CWA) and the Safe

Drinking Water Act (SDWA). The current methods approval process applies

to and is used by public and private laboratories, manufacturers of

analytical equipment and analysts who modify analytical methods or who

develop new methods for use in compliance monitoring under the CWA and

SDWA. The proposed rule only affects states if they choose to adopt the

proposed streamlined process as part of their laboratory auditing

programs. Under the streamlined methods approval system, EPA would

increase the analyst's flexibility to modify existing test procedures,

expedite approval of new and modified test procedures, establish and

require the use of standardized quality control (QC) and QC acceptance

criteria in existing and new test procedures, and recommend use of

standard data elements for reporting test results. Today's action

responds to the Administration's Environmental Technology and

Reinventing Government Initiatives and the National Technology Transfer

and Advancement Act by promoting use of emerging technologies and

encouraging participation of consensus standards organizations and

other organizations in developing test procedures (analytical methods).

The action proposed in today's rule would increase the options

available to the regulated community in complying with EPA regulations

under the CWA and SDWA. These actions are only an initial and interim

step in the Agency's pursuit of a performance-based approach to

environmental measurements, and are not meant to define or limit the

Agency's ultimate implementation of a ``pure'' performance-based

measurement system. The increased flexibility provided by this proposed

action should significantly reduce the need for Agency review of

alternate test procedures and make it easier for the analyst to select

analytical methods that are most suited to specific regulatory

measurement needs.

DATES: Comments on this proposed rule will be accepted until June 26,

1997.

ADDRESSES: Send written comments to the Streamlining Methods Docket

Clerk, Water Docket (MC-4101), USEPA, 401 M Street, SW., Washington, DC

20460. Please submit an original and three copies of your comments and

enclosures (including references). To ensure that EPA can read,

understand and therefore properly respond to comments, the Agency would

prefer that commenters cite, where possible, the paragraph(s) or

sections in the proposed regulation or in the supporting documents to

which each comment refers. Commenters should use a separate paragraph

for each issue discussed. Commenters who want EPA to acknowledge

receipt of their comments should enclose a self-addressed, stamped

envelope. No facsimiles (faxes) or electronic mail (email) will be

accepted because EPA cannot ensure that they will be submitted to the

Water Docket. A copy of the supporting documents cited in this proposal

are available for review at EPA's Water Docket, 401 M Street, SW.,

Washington, DC 20460. For access to docket materials, call 202/260-3027

between 9:00 a.m. and 3:30 p.m. for an appointment.

FOR FURTHER INFORMATION CONTACT: Dr. Richard Reding, USEPA, Office of

Ground Water and Drinking Water (MS-140), 26 W. Martin Luther King

Drive, Cincinnati, OH 45268, 513/569-7961.

SUPPLEMENTARY INFORMATION: The supporting documents that are a part of

the administrative record for this proposal may be obtained from the

National Center for Environmental Publications and Information (NCEPI)

(513/489-8190), from the National Technical Information Service (NTIS)

(703/487-4650), from the Educational Resources Information Center

(ERIC) (800/276-0462), and via the Internet on the EPA Office of Water

home page at http://www.epa.gov/watrhome. These documents are titled,

Guide to Method Flexibility and Approval of EPA Water Methods, December

1996 Draft, EPA-821-D-96-004, NTIS PB97-117766, ERIC D-A43 or D-A46

(diskette) (Streamlining Guide, EPA 1996a), Methods for Organic

Chemical Analysis of Municipal and Industrial Wastewater, December

1996, EPA-821-B-96-005, NTIS PB97-125298, ERIC D-A44 or D-A47

(diskette) (Organic Methods, EPA 1996b), and Guidelines and Format for

Methods to Be Proposed at 40 CFR Part 136 or Part 141, July 1996, EPA-

821-B-96-003, NTIS PB96-210448, ERIC D-A42 or D-A45 (diskette) (Method

Guidelines and Format, EPA 1996c).

Regulated Entities

Entities potentially regulated by this action are those who seek

EPA approval of analytical technologies for monitoring under the

provisions of the CWA and SDWA. Entities potentially regulated by this

action are listed in the table below. These entities potentially

include consensus methods organizations that publish compendiums of

analytical methods for water, and equipment manufacturers, instrument

manufacturers and laboratories that modify compliance methods or seek

approval of new methods for compliance monitoring.

------------------------------------------------------------------------

Category Examples of regulated entities

------------------------------------------------------------------------

Public............................ Government laboratories that develop

analytical methods for compliance

with the CWA and the SDWA.

Private........................... Commercial laboratories, consensus

methods organizations, instrument

manufacturers, vendors, and other

entities that develop or publish

analytical methods for compliance

with the CWA and the SDWA.

------------------------------------------------------------------------

This table is not intended to be exhaustive, but rather provides a

guide for readers regarding entities likely to be regulated by this

action. This table lists the types of entities that EPA is now aware

could potentially be regulated by this action. Other types of entities

not listed in the table could also be regulated. To determine whether

your organization is likely to be regulated by this action, you should

carefully read the applicability language of today's rule at

Secs. 136.4, 136.5 and 141.27. If you have questions regarding the

applicability of this action to a particular entity, consult the

individual listed in the preceding FOR FURTHER INFORMATION CONTACT

section.

Table of Contents

I. Authority

A. Clean Water Act

B. Safe Drinking Water Act

II. Background and History

A. Introduction

B. Current Office of Water Methods Approval Programs

C. Streamlining Initiative

D. Streamlining Objectives

[[Page 14977]]

E. Public Meetings and Stakeholder Participation in Streamlining

Development

F. Preamble Structure

III. Summary of Proposed Rule

A. Method Flexibility

1. Reference Method

2. Method Modifications

B. Quality Control

1. Standardized Quality Control Elements

2. Development of QC Acceptance Criteria

C. Method Validation for Modified or New Methods

1. Validation Study Plan

2. Testing

Table I. Summary of Validation Requirements for New Methods and

Method Modifications

3. Validation Study Report

4. Further Validation of a New Method

5. Approval of a Screening Method as a New Method

D. Method Review and Approval

Table II. EPA Review and Action for New and Modified Methods

1. Review and Approval of New Methods

2. Review and Approval of Modified Methods

3. Submission Package

4. Regulatory Assistance Provided by Submitter

5. EPA Review of Submission Package

6. Proposal of Methods

E. Other Issues

1. Legal Impacts

2. Method-defined Analytes

3. Biological Methods

4. Proprietary Reagents, Instruments, and Methods

5. Restrictions by Consensus Standards Organizations

6. Standard Data Format

7. Withdrawal of Outdated Methods

8. Administrative Record: Organic Methods, Streamlining Guide,

and Method Guidelines and Format

9. Coordination with Other Federal Register Proposals

IV. Regulatory Analysis

A. Executive Order 12866

B. Unfunded Mandates

C. Regulatory Flexibility Act

D. Paperwork Reduction Act

V. Request for Comments

A. General

B. Specific

VI. References

I. Authority

A. Clean Water Act

The Clean Water Act (CWA) requires the U.S. Environmental

Protection Agency (EPA) Administrator to promulgate effluent

limitations guidelines for specified categories and classes of point

sources. Section 301 of CWA prohibits the discharge of any pollutant

into navigable waters unless the discharge complies with a National

Pollutant Discharge Elimination System (NPDES) permit issued under CWA

section 402. Section 307 requires the EPA Administrator to publish

regulations establishing pretreatment standards for introduction of

pollutants into publicly owned treatment works (POTWs). Section 401

requires State and Tribal certification of a federal license that may

result in any discharge into the navigable waters.

Section 304(h) of CWA requires the EPA Administrator to promulgate

guidelines establishing test procedures for data gathering and for

monitoring compliance with published guidelines. EPA's promulgation of

analytical methods is authorized under this section of CWA, as well as

the general rulemaking authority in CWA section 501(a). The section

304(h) test procedures (analytical methods) are published or

incorporated by reference at 40 CFR part 136. They include Methods for

Chemical Analysis of Water and Wastes (MCAWW); the EPA 200-, 600-, and

1600-series methods; methods published by consensus standards

organizations such as ASTM, AOAC-International, and Standard Methods

for the Examination of Water and Wastewater (Standard Methods)

published jointly by the American Public Health Association (APHA), the

American Water Works Association (AWWA), and the Water Environment

Federation (WEF); methods used by the U.S. Geological Survey; methods

developed by third parties; and other methods referenced in CWA

regulations. These methods support development of effluent limitations

guidelines and standards promulgated at 40 CFR parts 405-503, establish

compliance with NPDES permits issued under CWA section 402, allow

implementation of the pretreatment standards issued under CWA section

307, and apply to the certification of compliance with State water

quality standards under CWA section 401.

B. Safe Drinking Water Act

The Safe Drinking Water Act (SDWA) requires the EPA Administrator

to promulgate national primary drinking water regulations (NPDWRs) that

specify maximum contaminant levels (MCLs) or treatment techniques for

listed drinking water contaminants (section 1412). Section 1445(a)

authorizes the Administrator to establish regulations for monitoring to

assist in determining whether persons comply with the requirements of

SDWA. EPA's promulgation of analytical methods is authorized under

these sections of SDWA, as well as the general rulemaking authority in

SDWA section 1450(a).

SDWA section 1401(1)(D) specifies that NPDWRs contain criteria and

procedures to ensure a supply of drinking water that dependably

complies with MCLs, including quality control (QC) and testing

procedures to ensure compliance with such levels and to ensure proper

operation and maintenance of drinking water supply and distribution

systems. These test procedures are promulgated at 40 CFR part 141 and

include three MCAWW methods, the 200-, 300-, and 500-series EPA

methods, methods published by consensus standards organizations, and

other methods referenced in SDWA regulations. EPA uses these test

procedures to establish MCLs under SDWA section 1412 and to establish

monitoring requirements under SDWA section 1445(a).

II. Background and History

A. Introduction

Within EPA, the Office of Water (OW) publishes analytical methods

for use in data gathering and environmental monitoring under the Clean

Water Act (CWA) and the Safe Drinking Water Act (SDWA). These methods

have been developed by EPA, by consensus standards organizations, and

by others. Many of these methods, especially those published before

1988, are prescriptive, with limited flexibility to change technologies

to respond to specific situations or to incorporate advances in

measurement technology. There has been a growing awareness, both within

EPA and in the analytical community, that the requirement to use

prescriptive measurement methods to comply with Agency regulations has

imposed an unintended regulatory burden and potentially created a

barrier to innovation in environmental monitoring.

To reduce this regulatory burden and to lower the barriers to

innovation, the Agency in a future rulemaking may propose to adopt a

completely performance-based approach to environmental measurements. As

envisioned under such an approach, the Agency would specify the

question(s) to be answered by the measurement, the decision(s) to be

supported by the data, and the level of uncertainty that is acceptable.

EPA would specify performance criteria for the measurement and data

producers would be required to demonstrate that their proposed

measurement system (i.e., methods, sample handling procedures) meets

these specific performance criteria. Data producers would be required

to document performance and certify that they have used appropriate

quality assurance and QC procedures. The system would apply to

physical, chemical, and biological measurements

[[Page 14978]]

conducted either in laboratories or in the field (EPA 1996d).

In a series of steps designed to adopt the performance-based

approach, each program office in the Agency has developed (or will

develop) an implementation plan that describes how the performance-

based approach would be put into practice. The Agency's goal is to have

these implementation plans as consistent as possible (i.e.,

``harmonized'') from program to program (EPA 1996e). The streamlining

initiative proposed in today's notice describes how EPA's Office of

Water is taking immediate steps to remove some of the regulatory

barriers to the use of new technologies for environmental measurements

of chemical analytes under the CWA and SDWA. This initiative would use

reference chemical methods that contain performance criteria and

methods that are already approved at 40 CFR parts 136 and 141. Other

implementation approaches to a performance-based measurement system,

such as listing in the CFR only the required performance criteria for

the measurement, are also possible; these approaches, which are not the

subject of today's proposal, may be the subject of future rulemakings.

Today's rule proposes a process that would use standardized QC, QC

acceptance criteria, and method validation procedures for stakeholders

to gain approval of new and modified methods for compliance monitoring

under the SDWA and CWA. Today's rule also proposes to designate certain

approved drinking water and wastewater methods as reference methods.

The approved reference methods either presently contain QC acceptance

criteria, are supplemented with these criteria in today's proposal, or

would be supplemented with these criteria in a future rulemaking. In

subsequent rulemakings, EPA intends to extend the streamlined method

approval process to physical and biological (including microbiological)

measurements in the water programs.

Through public meetings, announcements, and technical

presentations, EPA's Office of Water has coordinated this streamlining

initiative with various EPA Headquarters offices, EPA Regions, the

States, other governmental agencies, industry, consensus standards

organizations, environmental laboratories, and other interested

parties. With today's proposal, EPA attempts to define a comprehensive

program to increase analytical choices in selection of compliance

monitoring methods and to streamline the procedures for approval of

water methods. In this initiative, EPA seeks to promote rapid

introduction of innovative technologies, to encourage non-EPA

organizations to participate in the method development and approval

process, and to implement procedures to expedite the review and

approval of new and modified methods. Most importantly, EPA believes

that this initiative also offers the opportunity to improve the quality

of environmental monitoring.

The proposed streamlined procedures for approval of water methods

would allow analysts to use professional judgement to modify and

develop alternatives to established Agency methods and to take

advantage of emerging technologies that reduce costs, overcome

analytical difficulties, and enhance data quality. The proposal to

increase the flexibility to modify reference methods would be governed

by QC acceptance criteria designed to ensure that the quality of the

environmental data would not be compromised. These criteria would be

used to demonstrate that a modified method produces results equal or

superior to results produced by the reference method. EPA also proposes

to require that all new methods contain such QC acceptance criteria so

that modifications could be made to new methods.

EPA believes that allowing reference method modifications and

providing rapid approval of new methods would yield several benefits.

On behalf of regulated entities, analysts could select the analytical

method that yields the best performance in a specific situation. The QC

acceptance criteria in the reference method would enable the analyst to

document equivalent or superior performance to the satisfaction of

reviewing authorities. New technologies could be utilized to overcome

matrix interference problems, lower detection limits, improve

laboratory productivity, or reduce the amount of hazardous materials

used and hazardous wastes produced in the laboratory.

A more flexible method approval program is consistent with the

Administration's Environmental Technology and Reinventing Government

initiatives and the National Technology Transfer and Advancement Act of

1995 (NTTAA). The proposed program would empower stakeholders while

decreasing demands on Agency resources and is intended to accelerate

environmental technological innovation while enhancing and maintaining

environmental protection. EPA believes that the incentives provided by

a more flexible water test methods approval program would spur the

development of new technologies and, with them, new jobs. EPA also

anticipates that the use of new technologies may lower the cost of

environmental measurements, thereby reducing costs of environmental

compliance for American industries and municipalities.

B. Current Office of Water Methods Approval Programs

Requirements for approval of alternate analytical techniques

(methods) are specified at 40 CFR 136.4 and 136.5 for wastewater and at

40 CFR 141.27 for drinking water methods. These requirements are the

basis for the Agency's alternative test procedures (ATP) program for

water methods. Under the ATP program, persons may request approval to

modify steps in a reference method or approval to use a new method. The

person that submits the ATP application is responsible for validating

the new or modified method. Agency staff review the ATP validation

package and, if required, successful applications undergo formal

rulemaking. Rulemaking is required when a new or revised method is to

be added to the list of approved methods in the CFR. The ATP and

rulemaking processes make heavy demands on stakeholder, contractor,

EPA, and Office of Federal Register resources. The process can require

one to two years to gain approval of a method. Because advances in

analytical technology continue to outpace the capacity of OW's methods

approval program, the program is slow to respond to emerging

technologies and has been under-utilized. Under the streamlining

initiative described below, EPA proposes to increase method flexibility

by amending the procedures at 40 CFR 136.4, 136.5 and 141.27 to specify

a more rapid and less resource intensive process for approval of new

technologies.

C. Streamlining Initiative

The proposed streamlining initiative is designed to improve overall

resource use while making the method development process more efficient

and accessible to non-EPA organizations. The goals of the initiative

are to decrease the need for developers of modified methods to use the

ATP program and to speed up the approval (or disapproval) of methods

subject to ATP review. EPA believes the streamlining initiative would

(1) encourage the use of emerging technologies by increasing the

flexibility to modify approved methods without formal EPA approval, (2)

provide a mechanism for non-EPA organizations to develop and submit new

methods for

[[Page 14979]]

approval, and (3) expedite the approval of new and modified methods by

improving the current ATP program. This initiative applies to approval

of wastewater and drinking water methods. Because of current emphases

on decreasing redundant activities, forming partnerships with

stakeholders, and more quickly adopting advances in technology, EPA

believes this is an appropriate time to look to organizations outside

of EPA for assistance in developing new methods that take advantage of

emerging technologies that reduce costs, overcome analytical

difficulties, and enhance data quality. Once the streamlining

initiative is in place, EPA expects to increase its reliance on outside

organizations as the developers of many new methods. EPA would focus

its method development activities on specialized or esoteric methods

needed to support regulation development or compliance monitoring.

OW has coordinated the development of the streamlining initiative

with various governmental entities, industry, consensus standards

organizations, environmental laboratories, and other interested

parties. These organizations include the National Environmental

Laboratory Accreditation Committee (NELAC), and the Interagency

Steering Committee for Quality Assurance for Environmental

Measurements, which includes representatives from the Department of

Energy, Department of Defense, EPA, Air Force, U.S. Army Corps of

Engineers, U.S. Geological Survey (USGS), Bureau of Reclamation, and

other organizations.

D. Streamlining Objectives

The purpose of the streamlining initiative is to implement a more

performance-based approach to environmental measurements under the SDWA

and CWA. The proposed streamlined methods approval procedures would

revolutionize the water methods approval program to expand the

flexibility to modify existing methods, provide a mechanism for non-EPA

organizations to gain approval of new methods, and expedite the

approval of new and modified methods. EPA has defined several specific

streamlining objectives:

Increase the current flexibility to modify approved

chemical test procedures (methods) without formal EPA approval; this

would allow laboratories to overcome matrix interferences and would

facilitate early introduction of innovative technologies.

Designate a reference method for each unique

combination of analyte and determinative technique and establish

standardized QC tests for approved methods to ensure data quality.

Develop and publish QC acceptance criteria for any

reference method that does not have these criteria so that

laboratories can demonstrate equivalent or superior performance of a

modified method.

Provide a standard method format and mechanism for

validation and approval of new methods to expedite method approval

and to increase confidence in the validity of the methods and

resulting data.

Encourage stakeholder participation in method

development to keep pace with emerging technologies.

Harmonize the wastewater and drinking water test

procedures to eliminate unnecessary inconsistencies.

Increase standardized data reporting by recommending

use of standard data elements for reporting analytical results for

environmental and QC samples.

Identify and propose withdrawal of outdated or obsolete

methods from 40 CFR parts 136 and 141 to modernize approved test

methods and to eliminate methods that are no longer published by the

issuing government agency, consensus methods organization, or

vendor.

Work with the Office of Federal Register to incorporate

more methods by reference to reduce the volume of material published

in the CFR while ensuring and improving access to those methods by

all interested parties.

E. Public Meetings and Stakeholder Participation in Streamlining

Development

EPA conducted four public meetings to develop a streamlined water

test methods approval program. EPA held the meetings in Seattle,

Washington, on September 28, 1995; in Boston, Massachusetts, on January

25, 1996; in Chicago, Illinois, on February 14, 1996; and in Denver,

Colorado, on July 24, 1996. The purpose of the meetings was to present

and discuss EPA's draft of the streamlining initiative and obtain

stakeholder advice for refining the streamlining approach prior to

proposal.

All meetings were announced in the Federal Register in advance. The

first meeting, held in Seattle, was announced on September 12, 1995, in

a Federal Register notice titled, ``A Public Meeting and Availability

of Documents on Streamlining Approval of Analytical Methods at 40 CFR

part 136 and Flexibility in Existing Test Methods'' (60 FR 47325). This

Federal Register notice provided supplementary information regarding

the streamlining effort and made available several supporting

documents. Subsequent public meetings in Boston and Chicago were

announced on December 18, 1995 (60 FR 65207), and the fourth public

meeting in Denver was announced on July 10, 1996 (61 FR 36328). The

supporting documents and summaries of the four public meetings are in

the rule docket.

In addition to the public meetings, EPA solicited support and

expertise from each of the consensus standards organizations and

government agencies that developed the methods already approved for use

under the wastewater and drinking water programs. These groups include

the American Public Health Association (APHA), American Water Works

Association (AWWA), and Water Environment Federation (WEF) as

publishers of Standard Methods for the Examination of Water and

Wastewater (Standard Methods); ASTM (formerly, American Society for

Testing and Materials); AOAC-International (formerly, the Association

of Official Analytical Chemists); and the USGS. EPA also provided the

opportunity for individuals, the regulated industry, the States, local

permitting authorities, vendors, laboratories, and laboratory

organizations such as the International Association of Environmental

Testing Laboratories (IAETL), to voice opinions at the meetings. The

groups offered valuable insight concerning problems with the current

program and recommended areas of improvement.

Through the public meeting process and through individual meetings

with key stakeholder organizations, EPA received input from more than

400 stakeholders, including all major stakeholder organizations.

Following the first three public meetings, EPA compiled and

reviewed preliminary stakeholder advice to assess the initial response

to streamlining and revise the approach accordingly. In response to

stakeholder suggestions, EPA made the following changes to the

streamlining initiative:

Included drinking water methods (40 CFR part 141);

Expanded flexibility to allow changes to the

determinative technique;

Qualified flexibility to clarify that flexibility in

front-end techniques does not apply to sample collection and

preservation;

Expanded Tier 1 validation to allow single-laboratory

application of a method modification to multiple matrix types;

Added an option to have EPA review Tier 2 and Tier 3

method modifications upon request;

Added an option to have EPA formally approve, upon

request, Tier 2 and Tier 3 method modifications through rulemaking;

and

Added an option to submit screening methods to EPA for

approval.

The Streamlining Guide (EPA 1996a) and Method Guidelines and Format

(EPA 1996c) served as the revised draft of the streamlining initiative

that was discussed at the final public meeting on streamlining held in

Denver. This

[[Page 14980]]

proposed rule incorporates suggestions received at the Denver public

meeting, at previous public meetings, by mail, by electronic mail, and

in informal discussions with and among EPA personnel, EPA contractors,

and stakeholders.

Based upon the extensive involvement of internal and external

parties, and the generally favorable response, EPA anticipates that the

proposed regulations will be well received by regulatory authorities,

the regulated community, the technology development community, and the

laboratory service community.

F. Preamble Structure

Section III of this preamble outlines the key elements of

streamlining. Section III.A describes EPA's proposal for increased

flexibility within the method approval program and increased

flexibility for modifications to existing methods. Section III.B

describes the standardized QC requirements and QC acceptance criteria

associated with implementation of flexibility. Section III.C describes

the requirements for validating new methods and method modifications,

using a system based on the intended application of the method or

modification. Section III.D describes the expedited method approval

process and includes procedures for submitting validated methods to EPA

for approval. Section III.E describes other issues associated with the

streamlining initiative. The descriptions in Section III delineate the

framework of EPA's method flexibility and methods approval streamlining

initiative. The Streamlining Guide (EPA 1996a) and other supporting

documents cited in this notice contain specifics about the start-up and

operation of the proposed streamlining initiative.

III. Summary of Proposed Rule

A. Method Flexibility

In developing plans to improve the method approval program for

drinking water and wastewater methods, EPA concluded that the program's

success would depend largely on its ability to reflect the latest

advances in technology. This required, in turn, that the program be

efficient and flexible enough to encourage the development and use of

new measurement techniques. To meet these objectives, EPA determined

that the improved program would have two types of flexibility:

(1) Flexibility to modify reference methods without seeking formal

approval through the regulatory process, and

(2) Flexibility to develop and submit for approval entirely new

methods.

The first type of flexibility is primarily an expansion of the

flexibility already provided in some approved water methods. Under the

streamlining program, it would no longer be necessary to apply for ATP

approval of a method modification, because an analyst would only need

to demonstrate and document that the modified method produces results

equal or superior to results produced by an EPA-designated reference

method. A designated reference method that contains QC acceptance

criteria against which performance of a method modification could be

measured would be the primary control to ensure data quality. Other

controls would include specific multi-laboratory and multi-matrix

requirements for validating modified methods and checklists for

documenting equivalency.

The second type of flexibility would expand the ATP concept by

providing a mechanism whereby entirely new techniques would be

submitted to the Agency for approval, even when these techniques would

not serve as alternates to currently approved methods.

In designing a framework through which this flexibility could be

implemented, EPA sought to balance the advantages of increased

flexibility against the concern that results produced by modifications

would be inferior to results produced by approved methods. To ensure

that these competing objectives could be met, EPA has devised a

framework that is based on:

(1) Use of a standardized QC program with elements that could be

applied to all new and existing methods, and that is stringent enough

to meet compliance monitoring objectives, extensive enough to be

applied to a wide variety of analytical procedures, and yet simple

enough to avoid unwieldy or unnecessary restrictions;

(2) Development and application of QC acceptance criteria for each

QC element against which method modifications could be assessed and

documented; and

(3) Designation of a single reference method for each unique

combination of analyte and determinative technique. This reference

method would contain the QC acceptance criteria used to assess each QC

element for method equivalency.

In today's proposed revisions to 40 CFR parts 136 and 141, EPA

would define the QC elements and associated acceptance criteria (e.g.,

calibration, sensitivity, accuracy, precision) necessary to demonstrate

the equivalency of a modified method to a reference method. These

proposed QC requirements are based on the three components outlined

above. Once equivalency was demonstrated, a modified method could be

used immediately without review by EPA because EPA would have

``preapproved'' the modified method.

EPA believes that incorporating method flexibility into approved

analytical methods would improve laboratory operations by allowing

analysts to rely on professional judgement to ascertain the procedures

and protocols necessary to obtain the best results. Analysts could

employ new technologies to overcome matrix interferences, lower

detection limits, improve the reliability of results, reduce the

generation of hazardous wastes, improve laboratory productivity, and

reduce analytical costs.

1. Reference Method

The foundation of the flexibility concept is the use of a reference

method. For each unique combination of analyte and determinative

technique, EPA has identified or would designate one approved method as

the reference method. If the performance of the modified method is

equal or superior to the performance of the reference method, the

method modification would be allowed. EPA believes that the use of a

reference method with defined QC acceptance criteria as the performance

measure provides a means for implementing the streamlining initiative.

This approach would clarify and reduce the effort required to

demonstrate the equivalency of method modifications.

To implement the streamlining initiative, all reference methods

would need to specify standardized QC and QC acceptance criteria. The

QC and QC acceptance criteria would be necessary to demonstrate method

equivalency. Some methods, such as those approved at 40 CFR part 136,

Appendix A, already contain the necessary standardized QC and QC

acceptance criteria. Some other methods do not specifically identify

acceptance criteria for all of the standardized QC elements, but EPA

has the data from which such criteria could be developed. For this

proposed rule, selection of reference methods was based either on the

existence of QC acceptance criteria in the method or the availability

of data from which QC acceptance criteria could be developed. EPA is

proposing QC acceptance criteria for some inorganic analytes and

reference methods. These criteria are specified at 40 CFR 136.3 Table

IF and at 141.27(d) in the proposed rule text.

[[Page 14981]]

The remaining criteria for other analytes and reference methods would

be developed and proposed in subsequent rulemaking(s).

For some determinative techniques, no currently approved method

contained either all of the QC acceptance criteria proposed in today's

rule (e.g., Table ID in 40 CFR part 136) or sufficient data from which

to develop such criteria. In these cases, no reference method has been

proposed; therefore, all of those methods would be classified as other

approved methods. Without a reference method, users would not be able

to implement the method flexibility proposed in this streamlining

initiative.

EPA plans to include standardized QC with QC acceptance criteria in

all water methods under development and for all future water methods.

However, for drinking water methods, some of the QC acceptance criteria

(e.g., laboratory certification criteria) are currently (and may

continue to be) specified in drinking water regulations because these

criteria are an integral part of EPA's compliance monitoring

requirements.

In the future, the selection of a new reference method would depend

upon requirements imposed by the submitting organization, the

availability of standardized QC and QC acceptance criteria in the

method, and the timing of the selection. EPA intends to rely on outside

organizations to develop the majority of the new methods. Therefore, it

is anticipated that new reference methods for a particular

determinative technique would be designated by being the first method

approved for the given combination of analyte and determinative

technique. To become a reference method, the new method would need to

contain standardized QC and QC acceptance criteria, and be approved

through an Agency rulemaking.

The purpose of specifying a single reference method for a specific

combination of analyte and determinative technique is to avoid the

possible confusion that could be created if two or more reference

methods contained differing QC acceptance criteria. The QC acceptance

criteria associated with the single reference method would be the sole

criteria against which a method modification would be tested.

In today's action, EPA proposes to retain all methods approved for

use at 40 CFR parts 136 or 141, but would re-categorize each of these

methods as either a ``reference method'' or an ``other approved

method.'' Both types of methods would carry equal regulatory status.

The difference between the methods would be that the reference method

would contain (or would be supplemented with) detailed QC acceptance

criteria that would need to be used to assess the equivalency of a

method modification.

2. Method Modifications

Currently, explicit flexibility to modify a method is provided in

some of the approved 200-, 300-, 500-, 600-, and 1600-series methods

published by EPA. The allowed flexibility is typically specified

through use of the term ``should'' or the words ``or equivalent.''

Substitution of a 500-mL beaker for a 250-mL beaker or use of an

``equivalent'' chromatographic column are examples of such explicit

flexibility. The EPA 600- and 1600-series wastewater methods approved

at 40 CFR part 136, Appendix A, also provide limited flexibility to

improve separations and reduce the cost of measurements as long as

method performance is not sacrificed. As specified in those methods,

analysts who choose to exercise explicit flexibility are required to

meet the QC acceptance criteria of the approved method and to maintain

a record of the performance of the modified method for review at the

request of an auditor. In the development of more recent methods (e.g.,

Method 1664 and Method 1613), EPA expanded its definition of ``allowed

flexibility'' to further encourage use of new techniques that provide

equal or better performance at lower costs. However, no approved

methods provide unlimited flexibility and few provide the extensive

flexibility that EPA proposes in this initiative.

The categories of method modifications considered in this proposal

are: (1) Sample collection and holding procedures, (2) front-end

techniques, (3) determinative techniques, and (4) analyte addition.

These categories are defined below and described in terms of present

and proposed flexibility to modify the procedures or techniques

included in each category.

The first category, sample collection and holding procedures,

includes procedures and reagents used in the field, in transit, and at

the laboratory. This category includes sample containers, sample

holding times, preservation reagents and procedures, and shipping and

storage procedures and conditions. Currently, the Regional

Administrator may approve modifications to these procedures for

wastewater methods if the submitter so requests as specified at 40 CFR

136.3(c). In the drinking water program, except as explicitly allowed

in the compliance method, modifications of sample collection and

holding procedures would be approved through the ATP specification at

40 CFR 141.27.

The flexibility proposed in today's rule would not extend to sample

collection or holding procedures. Upon implementation of streamlining,

modifications to sample collection and preservation conditions would

continue to require EPA approval as specified at 40 CFR 136.3(c) and

141.27(b). The latter section, 141.27(b), is a proposed amendment of 40

CFR 141.27 that was written to conform more closely with the

modification provisions at 40 CFR 136.3.

Front-end techniques, the second category of method modifications,

are steps in the analytical process used at the laboratory that precede

the determinative technique and include all procedures, equipment,

solvents, etc., that are used to prepare a sample for analysis. The

third category is the determinative technique, which is defined as the

physical and/or chemical process by which an analyte is identified and

its concentration measured. For most methods, the determinative

technique consists of an instrumental measurement (e.g., a detector).

The fourth category covers increasing the analytical scope of a

reference method to include additional analytes.

Historically, the wastewater program has allowed some changes to

front-end techniques, but only a few methods allow changes to the

determinative step. The drinking water program has allowed similar

changes provided the chemistry of the method is not changed. This means

that some modifications, such as changing the extraction solvent, are

not allowed in drinking water methods unless they receive formal EPA

approval.

This proposed rule expands and more clearly defines proposed

modifications to approved methods. EPA proposes to allow the laboratory

analyst the flexibility to modify any and all front-end techniques,

provided the modification is not explicitly prohibited in the reference

method and provided the analyst demonstrates and documents that the

modification produces results equal or superior to results produced by

the reference method. The laboratory analyst would keep on file the

documents that demonstrate equivalency. Readers are referred to the

Streamlining Guide (EPA 1996a) for more guidance on this subject.

EPA considered restricting the flexibility to change front-end

procedures, such as extraction solvents,

[[Page 14982]]

solvent-to-sample volumes, extraction media, and pH, because such

changes require a deeper understanding of the measurement science than

some users may have. However, EPA is not proposing to restrict front-

end flexibility because EPA believes it is appropriate to allow the

method development and auditing communities an opportunity to comment

on a far-reaching change to the current system. The developer of a

modified method always would have the option to ask EPA or another

regulatory authority for a technical opinion on the acceptability of

the validation data that supports the method. In the list of questions

at the end of this preamble, EPA invites public comment on what, if

any, additional QC would be needed to document the acceptability of

front-end modifications to a reference method.

EPA proposes to allow use of an alternate determinative technique

that is not explicitly prohibited in the reference method, provided

that the analyst could demonstrate and document equivalency as outlined

above, and provided that four conditions could be met: (1) The

alternate determinative technique measures a property similar to the

prescribed technique, (2) the alternate technique is demonstrated to be

more specific (i.e., provides better separation of the analyte from

interferences) and/or more sensitive (i.e., produces a lower detection

limit) for the analyte of concern than the determinative technique in

the reference method, (3) there is not another approved method that

uses the alternate determinative technique for the determination of

that analyte, and (4) use of the alternate determinative technique

would not result in a nonsensical combination of analyte, front-end

technique, and determinative technique.

Examples of allowed changes to a determinative technique would be

substitution of a photoionization detector for a flame ionization

detector for determination of polynuclear aromatic hydrocarbons,

substitution of a nitrogen-phosphorous detector for an electron capture

detector (ECD) for determination of analytes containing nitrogen or

phosphorous, and substitution of a fluorescence detector for an

ultraviolet or visible wavelength detector. Substitution of a mass

spectrometer (MS) for an ECD would not be allowed if there is an

approved MS method that measures the analyte of concern. Readers are

referred to the Streamlining Guide (EPA 1996a) for more guidance on

this subject.

EPA proposes to limit changes to a determinative technique by the

four conditions described above to preclude nonsensical combinations of

analyte and determinative technique, to encourage a net benefit

(increased sensitivity and/or specificity), and to preclude multiple

reference methods with the same determinative technique but with

different QC acceptance criteria for the same analyte(s) of concern.

For example, if a mass spectrometer were substituted for the

conventional detectors in EPA methods 601-612, all of these methods

would become GC/MS methods, but all would contain different QC

acceptance criteria. Further, they would all conflict with approved GC/

MS Methods 625 and 1625. The proposed criteria for detector

substitution also would be consistent with EPA's decision in the

December 5, 1994, drinking water methods final rule (59 FR 62456) not

to allow substitution of MS in methods that specify conventional GC

detectors.

Another reason for proposing to limit changes to the determinative

technique is that there are techniques, such as immunoassay, for which

EPA has no reference method and therefore no history to ensure that the

standardized QC proposed in today's rule would be germane to, or

adequate for, assurance of the quality of data produced by the novel

determinative technique. EPA would prefer that a new method be written

and submitted for approval when a novel determinative technique is

developed. EPA invites public comment on the suitability of the

conditions EPA proposes to place on the flexibility to modify

determinative techniques in EPA reference methods.

In today's proposed rule, EPA also has specified how the analyst

would modify the analytical scope of a reference method to add

additional analytes. This option is proposed in response to public

comment on previous rules (59 FR 62456, December 5, 1994; 58 FR 65622,

December 15, 1993) to extend the scope of a reference method to the

determination of other analytes. Method developers seek this approval

when they want to adapt an existing method rather than develop a new

one to obtain occurrence data for a new analyte. EPA believes these

requests would have merit when there is a potential for new regulatory

requirements and historical monitoring data would be useful in making

process, treatment, or regulatory decisions. Examples of monitoring for

a new analyte would include industrial or POTW monitoring for ethers in

a discharge, public water system (PWS) monitoring for unregulated

pesticides or pesticide metabolites, and PWS monitoring for analytes on

the drinking water priority list. EPA also believes these requests

would have merit when technological advances would make the measurement

of additional analytes feasible (e.g., adding lead to the scope of EPA

Method 200.7). Under the proposed flexibility procedures for modified

and new methods, developers would obtain approval for the addition of

analytes to a reference method as an allowed method modification if the

conditions below would be met.

An analyst may add a new target analyte to a reference method

provided (1) it could be demonstrated that the analyte would not

interfere with determination of the analytes of concern in that method,

(2) QC acceptance criteria were developed and employed for

determination of the target analyte, (3) there would not be another

approved method that uses the same determinative technique for that

analyte, and (4) that the reason for adding the analyte would not be to

avoid the sample preservation or sample (or extract) holding time

conditions that are already required for that analyte in another

approved method. The third and fourth criteria would preclude method

shopping whereby an analyst might add analytes to a reference method

with less rigid QC acceptance, sample collection or holding time

criteria. Under the criteria proposed above, if a reference method for

an analyte of concern required acidification of the sample, an analyst

would not have the flexibility to modify a method that does not require

sample acidification to include analysis of the analyte of concern.

Modifications of this type would require EPA approval as a new method.

If QC acceptance criteria do not exist to allow addition of a new

analyte, the guidelines specified at 40 CFR part 136 Appendix E, at 40

CFR 136.4, 136.5 and 141.27 would be followed to develop and obtain

approval for these criteria. Alternatively, QC acceptance criteria for

the new analyte could be transferred from the criteria for an analyte

with similar chemical characteristics in the same method or from the

criteria for the analyte in another approved method. EPA provides

additional guidance on developing QC acceptance criteria in Chapter 3

of the Streamlining Guide (EPA 1996a).

B. Quality Control

In order to establish that method modifications do not degrade

method performance, a standard would be required against which changes

could be compared. This standard would consist of standardized QC

elements and QC acceptance criteria that would be listed in the

reference method and/

[[Page 14983]]

or in the regulations at 40 CFR parts 136 and 141. These criteria

would serve as definitive test criteria for evaluating the performance

of a method modification. As proposed, new methods would be required to

include QC acceptance criteria that were developed from a method

validation study according to procedures specified at 40 CFR 136.5,

141.27(c) and (e).

1. Standardized Quality Control Elements

The standardized QC elements, described below, when paired with the

relevant QC acceptance criteria for each element, would allow analysts

to establish and document method performance. These elements would be

specified at 40 CFR part 136 Appendix E and at 40 CFR 136.4, 136.5 and

141.27. Additional guidance on procedures and requirements for these QC

elements are provided in the Streamlining Guide (EPA 1996a).

Calibration--the process of establishing the

relationship between the concentration or amount of material

introduced into an instrument or measurement process and the output

signal.

Calibration Verification--the means of establishing

that instrument performance remains within pre-established limits.

Initial Precision and Recovery (IPR)--the mechanism to

demonstrate that a laboratory would produce reliable results with

the method prior to analysis of environmental samples. IPRs also

would demonstrate that a method modification produces results equal

or superior to those produced by a reference method.

Ongoing Precision and Recovery--a process that

demonstrates that a laboratory is able to produce reliable results

continuously.

Matrix Spike (MS)--a means to assess method performance

(especially analyte recovery) on a sample by adding a known amount

of the tested analyte.

Matrix Spike Duplicate--a process to test the precision

of an analysis by repeating the MS test.

Method Blank--a test that checks for laboratory

contamination.

Method Detection Limit (MDL)--the MDL test, as

specified at Appendix B of 40 CFR part 136, is used to confirm that

a laboratory is capable of detecting an analyte of concern at the

level specified in the method or at an acceptable level for

regulatory compliance monitoring.

Reference Sample--a test that serves as an external

check on method accuracy.

Retention Time and Relative Retention Time Precision--a

means to assess the performance of a chromatographic separation

system; used to aid in the identification of each target analyte in

a complex mixture.

Surrogate--a means to assess the performance of the

method within the given sample matrix by adding a known amount of a

different but chemically similar analyte. The results of these tests

would be used to assess method and laboratory performance.

For each reference method, each QC test would have acceptance

criteria that define data acceptability.

2. Development of QC Acceptance Criteria

QC acceptance criteria would be used to ensure that a modified

method produces results that are reliable, defensible and suitable for

regulatory decisions. QC acceptance criteria would be specified as

numeric limits. For example, the QC acceptance criteria for a MS/MSD

test may be 75-125 percent recovery with a relative percent difference

(RPD) of 20 or less. If these criteria were met for the MS/MSD test,

and all other QC acceptance criteria were met, results produced using

the modified method could be used for regulatory compliance purposes;

if not, corrective action would need to be taken and the sample

reanalyzed.

Some methods currently approved at 40 CFR parts 136 and 141

explicitly specify QC acceptance criteria for all of the standardized

QC elements outlined in today's proposal, but many do not. In selecting

reference methods for today's proposal, EPA chose those methods that

contained QC acceptance criteria or data from which QC acceptance

criteria could be developed. For those methods that did not contain QC

acceptance criteria, QC acceptance criteria were developed from results

of single-laboratory or interlaboratory study data contained in the

method or from criteria contained in Appendix D of 40 CFR part 136.

These criteria are provided at 40 CFR 141.27(d) and 136.3 Table IF for

drinking water and wastewater reference methods, respectively. EPA

would develop QC acceptance criteria for certain approved methods that

do not presently contain these criteria. EPA would propose to designate

these approved methods as reference methods in a future rulemaking.

C. Method Validation for Modified or New Methods

Method validation is the process by which an analyst or vendor

would establish the performance of a new method or would substantiate

the performance of a method modification to a reference method.

Validation would be necessary to demonstrate and document that the new

or modified method could yield reliable data for compliance monitoring

and other purposes. The party who developed the method or method

modification would be responsible for validating the method or method

modification.

The requirements for validation would depend on the level of

intended use for the method modification or new method, and the

characteristics of the sample to which the method modification or new

method would be applied. Based on interactions with stakeholders, EPA

proposes to establish three levels of validation:

Tier 1 methods would be used in a single laboratory in

a single matrix type from one industrial category or subcategory, or

in additional matrix types from any industrial category or

subcategory.

Tier 2 methods would be used by all laboratories in one

or more matrix types within one industrial category or subcategory.

Tier 3 methods would be used by all laboratories in

matrix types from all industrial categories or subcategories.

Proposed definitions of the terms laboratory, matrix type, medium,

and tier are in the definitions sections at 40 CFR 136.2 and 141.2. In

the streamlining initiative, the term matrix type would be defined and

used to identify a sample medium with common characteristics across a

given industrial category or subcategory. The terms facility or system

would identify places where an industrial discharge activity occurs or

where a water source is treated and distributed as drinking (potable)

water. For example, all POTWs that comprise the municipal wastewater

treatment industry would be considered to be in one industrial

category. A typical municipal POTW has three matrix types: untreated

wastewater, treated wastewater, and sludge. All PWSs that comprise the

drinking water industry would be considered to be in one industrial

category and to be one matrix type--potable water. Similar definitions

would apply to matrix types in other industrial categories and

subcategories. EPA invites public comment on these definitions and

seeks suggestions on additional terms or concepts for which the public

believes a regulatory definition would be useful in implementing and

administering EPA's methods approval system.

Method validation would comprise three steps: (1) development of a

validation study plan, (2) testing, and (3) preparation of a validation

study report.

1. Validation Study Plan

A validation study plan would be required for development of a new

method at any tier or for modification of a reference method at Tiers 2

and 3. The organization responsible for conducting the study would

prepare the validation study plan. Requirements for method validation

would be specified at 40 CFR 136.4, 136.5 and 141.27 and at 40 CFR part

136 Appendix E. Additional guidance on suggested validation study

[[Page 14984]]

plans is available in the Streamlining Guide (EPA 1996a).

A validation study plan would not be required for Tier 1 method

modifications, because EPA would expect that single-laboratory use

modifications would be simple and straightforward, and that requiring a

validation study plan for single-laboratory modifications would impose

an unnecessary regulatory burden on small laboratories.

2. Testing

The number of testing laboratories, matrices, and replicate QC

tests for the method validation would depend on the tier at which the

new or modified method would be validated, as indicated in Table I

below. The specific requirements and procedures for performing QC

validation testing are specified at 40 CFR 136.4, 136.5 and at 141.27;

additional guidance is available in the Streamlining Guide (EPA 1996a).

Table I, which is taken from 40 CFR 136.5(d), summarizes validation

requirements at each tier.

Table I.--Summary of Validation Requirements for New Methods and Method Modifications 1

--------------------------------------------------------------------------------------------------------------------------------------------------------

Number of Number of analyses required

------------------------------------------------------------------------------------------

Method application Matrix Facilities/ IPR-reagent IPR-sample

Labs types PWSs water 2 matrix 3 MS/MSD MDL \4\

--------------------------------------------------------------------------------------------------------------------------------------------------------

Tier 1-Single-lab WW/DW--First matrix type or first PWS...... 1 1 1 4 4 5 2 7

WW--Each addt'l matrix type (8 max.) from any industrial

category.................................................... 1 1 1 6 0 6 0 5 2 6 0

DW--Each addt'l PWS (2 max.)................................. 1 1 1 6 0 6 0 5 2 6 0

Tier 2-Multi-lab, single matrix type WW/DW--Each matrix type

in a single industrial category............................. 3 1 3 12 0 7 6 21

Tier 3-Multi-lab, multiple matrix types WW only--All matrix

types, all industrial categories............................ 8 9 9 9 36 0 7 18 63

--------------------------------------------------------------------------------------------------------------------------------------------------------

1 Numbers of analyses in this table do not include background analyses or additional QC tests such as calibration, blanks, etc. Validation requirements

are based on the intended application of the method. Method application would be designated by tier for wastewater (WW) and drinking water (DW)

programs. Three would be the maximum number of public water systems (PWSs) that would be required to validate a new or modified drinking water method

at Tier 1 or 2. Nine would be the maximum number of matrix types (or facilities) that would be required to validate a new or modified wastewater

method at Tier 1 or 3; at Tier 2 the number would be three matrix types.

2 IPR reagent water analyses would be used to validate a method modification and to establish QC acceptance criteria for initial precision and recovery

(IPR) and ongoing precision and recovery (OPR) for a new method. The required number of IPR analyses, except as noted under footnote 7, would be four

times the number of laboratories required to validate a method modification or new method because each laboratory would perform a 4-replicate IPR

test.

3 IPR sample matrix analyses would be used to establish QC acceptance criteria for matrix spike/matrix spike duplicate (MS/MSD) recovery and precision

for a Tier 1 new method only. Would not be required for validation of Tier 2 or 3 new methods because this variability data would be obtained from MS/

MSD tests. Would not be required for validation of a method modification because MS/MSD data from the reference method would be used.

4 A method detection limit (MDL) test would be performed in each laboratory using the new or modified method. 40 CFR part 136 Appendix B requires a

minimum of seven analyses per laboratory to determine an MDL. Each lab involved in validation of a wastewater modification would demonstrate that the

modified method would achieve the detection limits specified in the regulations at 40 CFR parts 136 and 141 and/or in chapter 6 of the Streamlining

Guide (EPA 1996a).

5 MS/MSD analyses would be required only for a method modification because, for new methods, the MS/MSD QC acceptance criteria would be established by

the 4-replicate sample matrix IPR test. For modified methods, the MS/MSD test would demonstrate that the reference method MS/MSD QC acceptance

criteria have been met.

6 The MDL, reagent water IPR, and sample matrix IPR tests would not have to be repeated after the first matrix type, facility, or PWS was validated.

7 For validation of a new method, the MS/MSD analyses would establish QC acceptance criteria for MS/MSD recovery and precision. For validation of a

method modification, the MS/MSD analyses would demonstrate that reference method MS/MSD recovery and precision have been met. The required number of

MS/MSD analyses would be two times the number of facilities, PWSs or matrix types tested.

8 The number of laboratories and samples would vary if a conventional interlaboratory study is used.

The tiered approach to validating new and modified methods would

accommodate variability in the analytical performance of a method that

can be attributed to the type of sample analyzed. This variability is

termed a matrix effect and can be observed in samples taken at

different locations in matrices of the same type (intramatrix) or in

samples from different locations and in different matrix types

(intermatrix). Under the streamlining initiative, each successive tier

addresses matrix effects to a greater degree through increasing levels

of sample matrix effect validation, broadly defined as a test of the

extent to which differences, if any, in method performance could be

attributed to variability between samples obtained from different

industrial matrices, facilities, or PWSs. Matrix effects would need to

be tested by the IPR sample matrix and MS/MSD analyses listed in Table

I. Intramatrix effects would need to be tested in water samples taken

from different PWSs or from different waste streams. Intermatrix

effects would need to be validated on a group of samples taken from

discharge samples collected from several different industrial

categories. In all cases, the laboratory would try to determine if the

measurement result for the target analyte using a new or modified

method differed from the result obtained in a reagent water matrix or

in a previously validated matrix type or PWS sample.

As indicated in Table I, a Tier 1 new or modified method would be

validated in a single laboratory on one or more matrix types obtained

from one or more facilities, or on samples obtained from one or more

PWSs. Validation of additional facilities or PWSs would require

analysis of MS/MSD samples for each additional facility or PWS.

However, in response to stakeholder requests that there should be some

maximum number of single-laboratory validations after which further

validation would be unnecessary because sample matrix effects would

have been sufficiently addressed, EPA

[[Page 14985]]

added a provision for a maximum number of matrix type, facility or PWS

analyses for Tier 1 methods. For a wastewater method, the maximum

number of matrix types or facilities tested under Tier 1 would be nine,

each from a different industrial category or subcategory. For a

drinking water method, the maximum number of PWS samples tested under

Tier 1 would be three samples, each from a PWS with different water

quality characteristics. EPA proposes to require validation in three

rather than nine PWSs, because three is consistent with the validation

data in many EPA drinking water methods and because the variability in

drinking water samples (and therefore the probability of matrix

effects) is usually less in drinking water samples than in wastewater

samples.

Tier 2 validation would be applicable to one or more matrix types

within a single industrial category or subcategory. Because Tier 2 new

and modified methods would apply to each matrix across all

laboratories, EPA developed Tier 2 validation requirements to

incorporate intramatrix variability. Tier 2 would require validation of

the method in drinking water samples obtained from three PWSs, or

wastewater samples of one or more matrix types obtained from three or

more facilities within a single industrial category or subcategory.

Tier 3 validation would be applicable to all matrix types in all

industrial categories. Consequently, Tier 3 validation requirements

would include provisions to account for both intramatrix and

intermatrix variability. However, Tier 3 validation would not apply to

the drinking water program because the program regulates only one

matrix type, drinking (potable) water. The wastewater program regulates

several industrial categories, each of which may contain more than one

matrix type. Tier 3 would require validation of the method in

wastewater samples of up to nine matrix types obtained from nine

different facilities.

For all multi-matrix tiers, it would be extremely important to

select suitable samples and matrix types for validation. The matrix

types, facilities, or PWSs selected for matrix effect validation would

need to have sufficiently different water quality characteristics so

that the matrix effects, if any, could be observed. Proposed criteria

for selecting matrix types, facilities, or PWSs from which to obtain

these samples is specified at 40 CFR 136.4(a)(2)(i) and 141.27(b)(iii).

Additional guidance on testing sample matrix effects is available in

the Streamlining Guide (EPA 1996a).

EPA invites public comment on the number of tests, laboratories,

matrix types, facilities, and PWSs that EPA is proposing for validation

of Tier 1, 2, or 3 methods. EPA is specifically interested in

suggestions for adding, deleting, or modifying the tests listed in

Table I. Commenters should provide EPA with reasons for (and preferably

data to support) any suggested changes.

3. Validation Study Report

A validation study report would be required for a new method or

method modification at all tiers to document successful validation. The

primary documents to be included in the report would be the Checklist

for Initial Demonstration of Method Performance, the Checklist for

Continuing Demonstration of Method Performance (collectively, the

``Checklists''), and a Certification Statement. The Checklists would

document that all requirements for establishing equivalency were met;

the certification statement would commit the persons involved in the

method development or modification effort to the statements made in the

Checklists and the supporting information provided. The proposed

Checklists would be specified at 40 CFR part 136 Appendix E. The

checklists also would be published in the Streamlining Guide (EPA

1996a) with additional guidance on how to complete a checklist for a

typical water method. This guidance would be provided to aid the method

modifier or developer in understanding the information and test data to

be provided. The Checklists and certification statement would be

required as part of the validation study report. For Tier 1 method

modifications, the Checklists and certification statement would

comprise the data validation report. For all tiers, each laboratory

involved in validation of a method modification would need to complete

the Checklists and Certification Statement. More extensive

documentation would be required for a modification at Tiers 2 and 3 and

for all new methods.

The validation study report for Tiers 2 and 3 would need to specify

the following information, as appropriate, for validation of a new or

modified method:

Narrative--includes (a) a description of the method

being validated and the matrices, matrix types, and media to which

the method is applicable; (b) an indication of whether the method is

a modification of an approved reference method or a new method; (c)

reason for and description of the modification, if applicable; and

(d) information on the organization responsible for developing the

new method or method modification.

Analyte(s)--name and Chemical Abstracts Service (CAS)

Registry Number or an EPA Environmental Monitoring Methods Index

(EMMI) Number. If a CAS Registry Number has not been assigned, the

submitter should attempt to obtain a number from the CAS Registry.

If the CAS Registry will not assign a number, the submitter should

contact the AMS Director for assignment of an EMMI Number. A report

for a modified method should indicate whether the modification

includes all forms of the analyte(s) in the scope of the reference

method. The definition of AMS Director is at 40 CFR parts 136.2 and

141.2.

Method or modified test procedure--prepared in a

standard format; modified test procedures would be prepared in the

format of the reference method.

Methodology and procedures--indicates the tier level at

which the new or modified method was tested, describes the approach

used to implement the study, describes the procedures used to report

and validate the data, and identifies the problems encountered

during implementation of the study.

Results--for modified methods, includes a summary of QC

results required by the reference method and corresponding QC

results obtained with the modified method.

Conclusions--describes the conclusions and limitations

of the study.

Discussion--critically examines the study results.

The following items would need to be included in appendixes to the

validation study report:

Calculations;

Raw data to allow an independent reviewer to verify

each determination and calculation performed by the laboratory;

For instruments involving data systems, raw data on

magnetic tape or disk (upon request only);

Names, titles, addresses, and phone numbers of analysts

who performed analyses and QA Officer who verified analyses; and

Completed Checklists and Certification Statement.

The validation study report for a new or modified method would need

to be retained on file by the organization responsible for developing

or applying the modification, and by regulated entities whose samples

are tested with the method modification. The party responsible for

developing and submitting the new method also would need to maintain on

file the complete records of all validation study tests including the

study plan, all laboratory results, the validation study report,

completed Checklists and Certification Statement, and other information

that supports the new method or method modification. All records would

need to be made available for review upon request to an auditor,

permitting authority, or other regulatory authority. These records

would need to be submitted to EPA if the method

[[Page 14986]]

developer elected to request formal approval of a method modification

at Tier 2 or 3.

4. Further Validation of a New Method

After completing a Tier 1, 2, or 3 validation study of a new

method, the organization responsible for developing the method would

need to document the study results in accordance with requirements

proposed at 40 CFR part 136 Appendixes E, F, and G and would need to

submit the results and the method to EPA for review and approval. If,

based on its review of the method, EPA concluded that the method was

not sufficiently rugged or reliable for its intended use, EPA would

require further method development and testing. The tests and studies

that would be performed would need to be determined on a case-by-case

basis as these situations arise and would depend on the analyte(s) and

the analytical system.

5. Approval of a Screening Method as a New Method

Methods currently approved for compliance monitoring at 40 CFR

parts 136 and 141 are considered to be confirmatory methods if the

method is sufficiently selective and quantitative so that most positive

results do not have to be verified by analysis with another method. The

term ``confirmatory'' is used to distinguish these methods from

screening methods. When using a screening method, all positive results

should be verified by re-analysis with a confirmatory method because

screening methods can be less selective and/or quantitative and,

therefore, more subject to false positives or imprecise results than

confirmatory methods. Characteristics of screening methods are

described in more detail in Chapter 2 of the Streamlining Guide (EPA

1996a).

EPA has been asked by many stakeholders to allow use of screening

methods for wastewater and drinking water analyses. Although screening

methods may be less selective and quantitative than confirmatory

methods, they also could be designed to serve meaningful uses under

those statutes. Screening methods could be especially useful when

measuring trends in the contamination of a water source or when

knowledge of the performance of a waste treatment process would be more

important than an exact knowledge of the absolute amount and identity

of the contaminant or pollutant.

Historically, EPA has not considered screening methods for approval

at 40 CFR part 136 or part 141. Under the streamlining initiative, EPA

proposes to consider the approval of screening methods for compliance

monitoring under the Safe Drinking Water Act provided that: (1) the

method would meet all the requirements specified in the regulations at

40 CFR 141.27, (2) all positive sample results obtained with the method

would be confirmed and reported using an approved confirmatory method,

and (3) the probability of the method producing a false negative result

at concentrations of regulatory interest would be no more than one

percent (1%). EPA has not yet specified how it intends to implement the

use of screening methods under the SDWA; the term was only recently

added in the 1996 SDWA amendments. Under the Clean Water Act, EPA is

considering the appropriateness of screening methods for use in NPDES

permit applications and ambient water quality monitoring by States. EPA

proposes to publish a separate table at 40 CFR parts 136 and 141 to

list approved screening methods. The Agency invites comment on the

approval criteria for screening methods for the uses described in the

SDWA, as well as for NPDES permit applications and ambient water

quality monitoring.

D. Method Review and Approval

Under this proposed rule, EPA expects to significantly reduce the

number of methods that would pass through the ATP review and rulemaking

processes. EPA has this expectation because, once implemented, the

streamlining initiative would make it easier for method modifications

to be judged as being ``within the flexibility allowed by the

streamlining initiative.'' Method modifications demonstrated and

documented to be within the flexibility allowed by the streamlining

initiative would be preapproved by EPA for use at the tier for which

the modification was validated. Stakeholder remarks suggest that most

laboratories and method development organizations would welcome and use

this allowed flexibility.

Stakeholders also have asked EPA to approve more quickly revised

versions of approved methods that are periodically published by EPA,

consensus standards organizations, and other government agencies. In

the past, EPA approved these revisions through a formal proposal and

public comment process. Using the flexibility provisions of today's

rule, users would be able to use a revised version of a reference

method as soon as it is published, provided that the results produced

were demonstrated to meet the QC acceptance criteria of the reference

method. This benefit alone would relieve much stakeholder frustration,

decrease the Agency's rulemaking burden, and improve EPA's partnership

with other government agencies and consensus standards organizations.

Table II summarizes EPA's review and rulemaking responsibilities

for new and modified methods by tier.

Table II.--EPA Review and Action for New and Modified Methods

------------------------------------------------------------------------

New Method Modified Method

------------------------------------------------------------------------

Tier 1, Single-lab.............. EPA review No EPA review.

required; EPA

issues a letter

of approval.

Tier 2, Multi-lab, single matrix EPA review If requested, EPA

type. required; reviews and

approved through --issues letter of

rulemaking. approval, or

--conducts

rulemaking.

Tier 3, Multi-lab, multiple EPA review If requested, EPA

matrix types. required; reviews and

approved through --issues letter of

rulemaking. approval, or

--conducts

rulemaking.

------------------------------------------------------------------------

1. Review and Approval of New Methods

Currently, all new methods must be approved by EPA through

``formal'' EPA approval including rulemaking and publication at 40 CFR

part 136 or 141 before use. In today's rule, EPA proposes to grant

letter approvals of new methods that would be submitted under Tier 1

(i.e., single-laboratory, limited-use methods). New methods developed

for use under Tiers 2 or 3 would still require rulemaking. The purpose

for not requiring formal rulemaking at Tier 1 would be to

[[Page 14987]]

provide the means by which (1) a new technology could be introduced,

(2) confidentiality of a new technology could be maintained if desired

by the user of the new method, and (3) specific matrix interference

problems could be overcome. Allowing use of Tier 1 new methods would

enable multiple single laboratories to use a new technology until a

sufficient number of devices were available for interlaboratory

validation as a Tier 2 or 3 new method.

EPA recognizes that allowing single-laboratory use of a new

technology for regulatory compliance carries with it the risk that

results produced with the new technology may not agree with results

produced by a reference method. However, EPA believes that sufficient

controls would be included in the streamlining program to ensure data

quality. EPA also believes that there would be a net benefit to the

regulated community by allowing new technologies that overcome matrix

interference problems. EPA solicits comment on this aspect of

streamlining, and is particularly interested in alternative ways EPA

might allow introduction of new technologies without rulemaking.

2. Review and Approval of Modified Methods

Under the streamlining initiative proposed in today's rule, method

modifications would not require formal EPA approval; they would be

preapproved provided the analyst demonstrates and documents equivalency

with or superiority to the reference method QC criteria. Although

formal approval of a modification would not be required under the

streamlining initiative, several stakeholders have commented that, in

practice, use of a method modification would require the consent of the

regulated entity and responsible regulatory authority. These

stakeholders also expressed concern that without formal EPA approval,

obtaining consent from the regulated entity and/or regulatory authority

would be difficult. In response to these comments, EPA proposes to

allow, but not require, laboratories, industry associations, consensus

standards organizations, instrument manufacturers, and others to submit

Tier 2 or Tier 3 method modifications for EPA review with the

anticipation of a letter from EPA documenting approval. Also, for those

seeking public recognition that their Tier 2 or 3 method modifications

have been demonstrated to be acceptable for use, EPA proposes to work

with the organization to approve the method at 40 CFR part 136 or 141.

EPA would not review, provide letters of approval, or conduct formal

rulemaking for Tier 1 method modifications.

EPA recognizes that preapproving method modifications poses

additional burdens for regulatory authorities, who may need to assess

the reasonableness and effectiveness of each modification. EPA

believes, however, that the Checklists, certification statement, and

accompanying instructions, which are proposed at 40 CFR part 136

Appendix E, and the validation report for the method modification,

which is proposed at 40 CFR part 136 Appendixes F and G, would provide

a regulatory authority the information necessary to make equivalency

assessments, and that this information would be presented in a

standardized and readily understandable format. To further assist

regulatory authorities in implementing this initiative, EPA has

included detailed guidance on assessing method modifications for

equivalency. This guidance is provided in Chapter 6 and in the

appendixes of the Streamlining Guide (EPA 1996a).

3. Submission Package

The items to be submitted to EPA for proposal of a new method at

Tier 2 or 3 would include the method validation study report, which

would include the method prepared in a standard format. If the

submitter requested formal rulemaking to propose the method for

publication in the CFR, information in a format suitable for inclusion

in a draft preamble would also be required. Additionally, the

submission packet would need to include all relevant supporting

documents.

To preclude a proliferation of potentially confusing formats, a

method should be submitted in a standard format. EPA recommends and

specifies the format that would be specified at 40 CFR part 136

Appendix F. This format is also detailed in Method Guidelines and

Format (EPA 1996c). Appendix F describes all elements of the format

prescribed by EPA's Environmental Monitoring Management Council (EMMC).

An objective of the EMMC format is to standardize all Agency analytical

methods. A standardized format used by a government agency such as the

U.S. Geological Survey or from a consensus standards organization such

as Standard Methods, ASTM, or AOAC-International could be used, but EPA

recommends that these formats be reserved for those organizations to

avoid the possible confusion over authorship. EPA would not accept

methods in non-standard formats because of the confusion that could be

created by a proliferation of method formats.

A new method would need to include the standardized QC elements and

QC acceptance criteria. The QC acceptance criteria would need to be

developed from data gathered in the method validation study. Chapter 3

of the Streamlining Guide (EPA 1996a) provides guidance on the detailed

technical requirements for developing criteria that meet the

requirements that would be specified at 40 CFR 136.4, 136.5 and 141.27

and at 40 CFR part 136 Appendix E.

4. Regulatory Assistance Provided by Submitter

Using procedures that would be specified at 40 CFR part 136

Appendix G, EPA would ask method submitters to assist EPA by providing,

as part of the submission package for methods to be proposed in the

Federal Register, information that would facilitate EPA's drafting of a

proposed rule. EPA would also ask submitters to provide technical

assistance, when necessary, in responding to public comments on the

submitter's method. Other assistance could be requested by EPA. The

information should be submitted in a format corresponding to the

preamble drafting conventions specified by the Office of the Federal

Register. Citations of examples for preambles are given in 40 CFR part

136 Appendix G and in the Streamlining Guide (EPA 1996a). Instructions

for drafting documents for the Office of the Federal Register are given

in the Document Drafting Handbook, for sale by the Superintendent of

Documents, Mail Stop: SSOP, Washington, DC 20402-9328 (Document 1993

O--351-677 QL3).

5. EPA Review of Submission Package

Upon receipt of a request for approval, EPA would first check the

submission packet for completeness. If all of the documentation was in

order, EPA would use an internal workgroup to assess the scientific

merit of the method or modification and to evaluate the validation

study for consistency and appropriateness. Should any problems be

identified, the workgroup would contact the submitter to resolve the

outstanding issues. If these issues could not be resolved, EPA would

take no further action on the submission. If all validation

requirements were met and the submission passed internal review, EPA

would either issue a letter of approval or begin the rulemaking

process. All method modifications are preapproved, but a submitter

would have the option to request an EPA letter of approval or to

request a formal rulemaking for Tier 2 and 3 method

[[Page 14988]]

modifications. All new methods would be subject to EPA review. For Tier

1 new methods, EPA would issue letter approvals; Tier 2 and 3 new

methods would require formal Agency rulemaking.

6. Proposal of Methods

For rulemaking, EPA would prepare the proposed rule based on the

draft preamble provided by the submitter. EPA would add the appropriate

updates to CFR tables or language and submit the proposed rule to the

Office of the Federal Register for publication. The proposed rule would

request public comment and allow a specified comment period (typically

60 days after publication in the Federal Register). At the end of the

comment period, EPA would forward significant public comments, if any,

to the method submitter. The submitter would need to provide technical

assistance to EPA in drafting responses to the comments. If the

comments could not be adequately addressed, EPA would not take final

action to approve the method. If all comments are addressed, EPA (with

assistance from the submitter) would need to complete a response-to-

comments document and prepare a final rule to approve the proposed

method. The final rule would state the date that the rule becomes

effective, typically 30 days after rule publication. As of this

effective date, the method would be approved (promulgated) and the

appropriate tables in the CFR would be updated.

To expedite approval of noncontroversial updates to methods, such

as revisions to the methods published by EPA, other government

organizations, and consensus standards organizations, EPA intends to

use ``direct final'' rulemaking. Direct final rules would be warranted

when the action would not be expected to elicit public comment to which

the Agency would normally respond (i.e., no adverse comment). In this

process, the final rule and the companion proposal would be published

simultaneously as a ``direct final rule'' in the Federal Register. In a

direct final rule, the proposed rule has a specific comment period and

the final rule has a later effective date. If no adverse public

comments are received during the comment period for the proposed rule,

the actions become effective on the effective date of the final rule.

If adverse comment is received, the companion final rule is withdrawn

and a second final rule that responds to the public comments is

prepared and published with a new effective date.

E. Other Issues

1. Legal Impacts

Stakeholders expressed concern regarding potential conflicts

between regulators and regulated entities when using modified methods.

For example, there was widespread concern over a situation in which a

discharger used a modified method and demonstrated compliance with a

regulatory concentration limit while a regulatory authority used the

unmodified reference method and obtained results suggesting that the

discharger was out of compliance.

Based on internal EPA discussions, it became apparent that the

streamlining initiative would work only if the modified method, once

demonstrated to be equivalent to the reference method, carried the same

legal force and effect as the reference method. Therefore, the

difference in results produced by the modified and unmodified methods

would be attributable not to the modification, but to differences in

results produced by two laboratories. This situation is no different

than the existing situation where two laboratories can produce

different results, one set of which is above and the other below, a

regulatory compliance limit. The legal resolution would therefore

remain the same as today--a decision would be made based on examination

of all the relevant data.

2. Method-Defined Analytes

The method flexibility introduced in today's proposal does not

extend to methods in which some part of the method ``defines'' the

analyte of concern. This type of analyte is termed a method-defined

analyte. Because method-defined analytes do not have a specific, known

composition, the result of the analytical measurement depends totally

on how the measurement is made. Examples of method-defined analytes

include adsorbable organic halides, biochemical oxygen demand, total

organic carbon, and whole effluent toxicity. Changes to the front-end

steps or the determinative techniques in these methods have the

potential of changing the result produced. EPA believes, however, that

certain parts of procedures for method-defined analytes could be

modified without adversely affecting method performance.

3. Biological Methods

EPA intends to expand method flexibility to include biological

methods, but not in today's proposal. Biological methods include both

the testing of an environmental sample for the presence of

microbiological material (e.g., bacteria, protozoa and viruses) and the

use of biological organisms to measure whole effluent toxicity (WET) of

an environmental sample. EPA believes that flexibility in testing for

biological material would be similar to the flexibility allowed in the

modification to chemical analytical methods. Both the front-end and

determinative techniques should be able to be modified when the

modifications produce equivalent or superior results. EPA has protocols

for some microbiological methods that are currently used in the ATP

program (EPA 1995a, b). In a future rulemaking, EPA may revise the

microbiology protocols to conform with streamlining and method

flexibility procedures. In keeping with Agency goals for a more

performance-based approach to all environmental measurements, EPA also

may develop and propose method flexibility and new method approval

procedures for biological methods and for microbiological parameters

not covered under current EPA protocols.

For WET methods, both new and modified methods are possible. New

methods may involve the use of a different taxonomic category other

than those currently listed at 40 CFR part 136. Method modifications

may be defined as the variation of one of the established summary test

conditions of the method, such as temperature or salinity. Method

modifications to the summary test conditions would not change the

acceptance criteria (e.g., control survival) which serve to identify

the standards of comparison of the ``reference method.'' EPA has not

sufficiently explored this issue to propose the specific requirements

to allow flexibility in all approved biological methods. Until EPA can

clarify the extent of acceptable flexibility, requests for changes in

biological methods would be reviewed and approved on an individual

basis.

4. Proprietary Reagents, Instruments, and Methods

Stakeholders expressed concern over the role of proprietary

components in the streamlined water method approval process. EPA

separates proprietary components into three categories: proprietary

reagents, proprietary instruments, and proprietary methods. EPA intends

to attempt to accommodate the inclusion of proprietary reagents and

instruments in the approval of analytic methods for compliance purposes

to the extent that such inclusion still provides an adequate

opportunity for public review and comment under the Administrative

Procedure Act. EPA does not anticipate,

[[Page 14989]]

however, that it could approve the use of proprietary methods for

determining compliance with regulatory requirements where the entire

method is claimed as ``confidential business information'' because the

opportunity for public review and comment might be restricted too

severely. If a proprietary method is patented, the method would be

considered for approval as a compliance method because the public would

be able to comment on the patented method. EPA believes the restriction

on approval of proprietary methods is not serious because reagents or

instruments, not complete methods, will continue to be the most common

proprietary components used in compliance methods.

Proprietary reagents and instruments are currently included for use

in approved methods and would continue to be allowed in approved

methods. The details of the proprietary elements would need to be

disclosed to EPA, but would be withheld from the public if the person

requesting protection for the confidential business information (CBI)

demonstrates that the information is entitled to confidential treatment

under 40 CFR part 2. Examples of proprietary components may include

immunoassay reagents and antibodies and liquid phases in GC columns;

e.g., DB-1, SPB-octyl, Dexsil'', etc. A new or

modified method submitted for EPA approval would need to include

language stating that the proprietary reagent or instrument could be

replaced by an equivalent. Changes made to the method after EPA

approval would require the manufacturer to demonstrate, through

supporting documentation, that the new proprietary equipment,

substance, or reagent would produce results equal or superior to

results produced with the material originally tested and on which the

method approval is based. Additionally, EPA would not propose a method

containing a proprietary reagent without accurate, specific

instructions for handling the reagent and for safe disposal of each

spent proprietary reagent and/or reaction product. When a material

safety data sheet (MSDS) would need to accompany the proprietary

material, the MSDS would be the appropriate vehicle to provide these

instructions. Submission of a complete MSDS with a new method would

satisfy EPA's need for instructions for safe handling and disposal of

the reagent.

5. Restrictions by Consensus Standards Organizations

As envisioned, this initiative allows modification to a reference

method, provided that the QC acceptance criteria are met. Many of the

methods approved at 40 CFR parts 136 and 141 were developed by

consensus standard organizations such as Standard Methods, ASTM, and

AOAC-International. EPA expects to rely on these and other consensus

standards organizations for future methods, as required by the National

Technology Transfer and Advancement Act of 1995 (NTTAA) and because of

limited Agency resources for method development.

Consensus standards organizations have expressed concern that a

modification to their methods would constitute a violation of the

method being considered a ``standard.'' Standard Methods, ASTM, and

AOAC-International have declined to allow unlimited modification of

their approved methods and, therefore, their methods could not serve as

reference methods nor be modified under the procedures outlined in this

initiative, as can be seen in the proposed CFR tables. This restriction

would not greatly affect the streamlining initiative because an EPA

method exists that would be used as a reference method for nearly all

analytes, and because most methods from consensus standards

organizations have sufficient internal flexibility to meet the

objectives of streamlining or are updated frequently to reflect recent

advances in technologies.

6. Standard Data Format

For this proposed rule, EPA would not establish a standard format

for the submission of analytical data because of the large variety of

formats currently in use. However, EPA strongly recommends the

Department of Energy's Environmental Management Electronic Data

Deliverable Master Specification (DEEMS) because it is comprehensive

and it would expedite processing of a submitter's request. DEEMS is a

list of data elements that laboratories should submit to document the

method modification process. A DEEMS data element dictionary is

provided in the Streamlining Guide (EPA 1996a).

7. Withdrawal of Outdated Methods

EPA also is considering withdrawal of methods that the Agency

believes are obsolete or are no longer used. For example, 40 CFR part

136, Table ID, footnote 3, references methods published in 1978 that

include thin-layer chromatography (TLC) methods. Because gas

chromatography and high performance liquid chromatography methods

provide better monitoring data and are more cost effective, most, if

not all, laboratories no longer use TLC methods. The TLC methods were

proposed for withdrawal in a previous notice (60 FR 53988, October 18,

1995), and EPA believes there may be similar outdated methods. EPA is

conducting a careful examination of Tables IA through IE of 40 CFR part

136 and of the tables at 40 CFR part 141, for obsolete or outdated

methods, and intends to propose withdrawal of those methods for which

newer methods are available.

8. Administrative Record: Organic Methods, Streamlining Guide, and

Method Guidelines and Format

EPA specifies several 600- and 1600-series analytical methods at 40

CFR part 136 Appendix A for analysis of organic chemicals. If the

Office of the Federal Register approves incorporation by reference of

the Appendix A methods, EPA will withdraw Appendix A and publish all of

these methods in the document Methods for Organic Chemical Analysis of

Municipal and Industrial Wastewater, December 1996, EPA-821-B-96-005,

NTIS PB97-125298, ERIC D-A44/D-A47 (Organic Methods, EPA 1996b). This

document is part of the administrative record for this proposed rule;

copies can be inspected or obtained from NTIS or other sources as

described in the ADDRESSES section above.

EPA also has drafted two guidance documents that are an integral

part of the administrative record for this proposed rule. The first

document, Guide to Method Flexibility and Approval of EPA Water

Methods, December 1996 Draft, EPA-821-D-96-004, PB97-117766

(Streamlining Guide, EPA 1996a), provides detailed guidance on the

overall streamlining initiative. The second document, Guidelines and

Format for Methods to Be Proposed at 40 CFR Part 136 or Part 141, EPA-

821-B-96-003, PB96-210448, July 1996 (Method Guidelines and Format, EPA

1996c), specifies the content and format required for new methods

developed by outside organizations. These documents are readily and

widely available to the public through NTIS, online, and other sources

listed in the ADDRESSES section above.

The Streamlining Guide (EPA 1996a) in particular was drafted to

help method developers use the procedures proposed in today's rule to

validate and obtain approval of new or modified methods. The guidance

was written for use by laboratory auditors, permittees, water

utilities, regulatory authorities,

[[Page 14990]]

purveyors of new technology, and analytical laboratory personnel. The

document is organized into seven chapters, some of which are procedural

and others are descriptive, as appropriate to the topic. Chapter 1

summarizes the proposed streamlining initiative. Chapter 2 describes

the proposed expanded method flexibility. Chapter 3 describes the

proposed standard quality control tests and useful statistical

procedures for developing QC acceptance criteria for new methods.

Chapter 4 describes the proposed tiered system for validating a new

method or a method modification. Chapter 5 describes the proposed

method approval process, a standard method format, and procedures for

submitting validated methods to EPA for approval. Chapter 6 provides

guidance for assessing the method equivalency. Chapter 7 describes

possible future plans to extend method flexibility to microbiological

and macrobiological methods.

The Streamlining Guide (EPA 1996a) also includes eight appendixes.

Appendix A provides a list of acronyms and abbreviations. Appendix B

provides a glossary of terms used in the streamlining initiative.

Appendix C provides examples of currently allowed method modifications.

Appendix D contains a DEEMS data element dictionary, which is a

Department of Defense reporting format that EPA suggests would speed

review of method validation data. Appendix E provides the EMMC method

equivalency checklists and certification statement. Appendix F provides

an example of a completed Appendix E checklist. Appendix G contains

bibliographic references. Appendix H describes EPA derived the proposed

QC acceptance criteria for inorganic chemicals, which are proposed at

40 CFR 136.3 Table IF and 141.27(d)., were calculated.

EPA proposes to make some of the information in the Streamlining

Guide (EPA 1996a) and Method Guidelines and Format (EPA 1996c) a

regulatory requirement. Specifically, EPA proposes to include much of

the information in Chapter 2 (Method Flexibility), Chapter 6 (Assessing

Method Equivalency), Chapter 5 (Method Approval Process) and Appendix E

(Equivalency Checklists) as a requirement for approval of drinking and

wastewater methods. EPA proposes to accomplish this by designating the

excerpts from Chapters 2, 5 and 6 as 40 CFR part 136 Appendix G and the

equivalency checklists in Appendix E as 40 CFR part 136 Appendix E.

Other provisions of the Streamlining Guide (EPA 1996a), including, but

not limited to, Table 4-2, definitions of standardized QC elements, QC

acceptance criteria for inorganic chemicals, would also be included at

40 CFR 136.2, 136.3 Table IF, 136.4, 136.5, 141.2, and 141.27. EPA

would also adopt most of the provisions in Method Guidelines and Format

(EPA 1996c) as Appendix F at 40 CFR part 136. EPA invites public

comment on these two guidance documents and solicits comments on

whether additional guidance in these documents should be a regulatory

requirement.

9. Coordination with Other Federal Register Proposals

On October 18, 1995 (60 FR 53988), EPA proposed to amend the list

of approved methods at 40 CFR part 136 by adding new or revised methods

for certain metal and inorganic analytes and by adding method citations

to Table IB and amending the incorporation by reference section

accordingly. EPA also proposed to withdraw approval of certain outdated

or rarely used analytical methods, as well as certain methods that

require use of hazardous or toxic reagents. As of today, EPA has not

promulgated a final rule implementing the proposed actions.

The methods proposed for withdrawal that relate to this

streamlining initiative are primarily the EPA 200-series flame atomic

absorption spectrophotometry (FLAA) methods. Although approval of the

EPA FLAA methods is proposed to be withdrawn, FLAA methods published by

ASTM, Standard Methods, AOAC-International, and USGS would remain

approved and would remain listed in 40 CFR 136.3, Table IB. Withdrawal

of approval of EPA FLAA methods would remove these methods as reference

methods and would remove the QC acceptance criteria associated with

these methods. The net impact would be that there would be no FLAA

method against which modifications would be made. EPA does not consider

this a serious limitation because four FLAA methods (ASTM, Standard

Methods, AOAC-International, and USGS) would remain approved for nearly

all metals and the flexibility afforded by these methods should

adequately cover method modifications.

In 1997, EPA intends to amend the regulations at parts 136 and 141,

as appropriate, to update outdated versions of methods to versions

published in the 19th edition of Standard Methods (APHA 1995), the 1996

Annual Book of ASTM Standards, Vols. 11.01 and 11.02 (ASTM 1996), and

in EPA's August 1995 manual titled, Methods for the Determination of

Organic Compounds in Drinking Water--Supplement III (EPA 1995c). If and

when the provisions of today's rule are promulgated, EPA expects to be

able to list these 1995 and 1996 versions of the compliance methods as

approved methods in the tables listed at 40 CFR parts 136 and 141. If

inclusion of these more recent versions would provide a basis to change

any of the QC acceptance criteria for the reference methods, the public

would be notified and provided with the opportunity to comment on the

new criteria.

10. Laboratory Certification and Laboratory Auditing

Broad requirements for States to have an approved laboratory

certification program for analysis of drinking water samples are

specified at 40 CFR 142.10(b)(3). EPA provides more specific help to

State certification officers through written and verbal guidance. To

improve the uniformity of these certification programs, some laboratory

certification officers, method developers, and vendors have asked EPA

to provide more specific regulatory requirements. Today's rule responds

to these requests by proposing standardized QC elements for all water

compliance methods at 40 CFR 136.2 and 141.2, and at Appendix G of 40

CFR part 136. To standardize and facilitate laboratory audits, EPA also

would recommend use of several detailed checklists for auditing both

modified and unmodified methods. These standardized checklists would be

specified at Appendix E of 40 CFR part 136. EPA understands that

increasing the analyst's current flexibility to modify steps in a

compliance method could make the conduct of laboratory audits more

difficult. However, EPA believes that the proposal to specify

standardized QC elements for all methods and to require that

laboratories use standardized checklists to document and check method

performance will ameliorate these potential problems. EPA invites

public comment and is especially interested in what additional action,

if any, the Agency should take to facilitate the auditing of water

laboratories.

IV. Regulatory Analysis

A. Executive Order 12866

Under Executive Order 12866 [58 FR 51,735 (October 4, 1993)], the

Agency must determine whether the regulatory action is ``significant''

and therefore subject to OMB review and the requirements of the

Executive Order. The Order defines ``significant regulatory action'' as

one that is likely to result in a rule that may: (1) Have an annual

effect on the economy of $100

[[Page 14991]]

million or more or adversely affect in a material way the economy, a

sector of the economy, productivity, competition, jobs, the

environment, public health or safety, or State, local, or tribal

governments or communities; (2) create a serious inconsistency or

otherwise interfere with an action taken or planned by another agency;

(3) materially alter the budgetary impact of entitlements, grants, user

fees, or loan programs or the rights and obligations of recipients

thereof; or (4) raise novel legal or policy issues arising out of legal

mandates, the President's priorities, or the principles set forth in

the Executive Order.

This regulation is not major because it is intended to reduce costs

through flexibility and innovation. Therefore, this regulation would

not result in a cost to the economy of $100 million or more; would not

result in a major increase in costs or prices for consumers or

individual industries; and would not have significant adverse effects

on competition, investment, innovation, or international trade.

It has been determined that this rule is not a ``significant

regulatory action'' under the terms of Executive Order 12866 and is

therefore not subject to OMB review.

B. Unfunded Mandates

Title II of the Unfunded Mandates Reform Act of 1995 (UMRA), Pub.

L. 104-4, establishes requirements for Federal agencies to assess the

effects of their regulatory actions on State, local, and tribal

governments and the private sector. Under section 202 of the UMRA, EPA

generally must prepare a written statement, including a cost-benefit

analysis, for proposed and final rules with ``Federal mandates'' that

may result in expenditures to State, local, and tribal governments, in

the aggregate, or to the private sector, of $100 million or more in any

one year. Before promulgating an EPA rule for which a written statement

is needed, section 205 of the UMRA generally requires EPA to identify

and consider a reasonable number of regulatory alternatives and adopt

the least costly, most cost-effective or least burdensome alternative

that achieves the objectives of the rule. The provisions of section 205

do not apply when they are inconsistent with applicable law. Moreover,

section 205 allows EPA to adopt an alternative other than the least

costly, most cost-effective or least burdensome alternative if the

Administrator publishes with the final rule an explanation of why that

alternative was not adopted. Before EPA establishes any regulatory

requirements that may significantly or uniquely affect small

governments, including tribal governments, it must have developed under

section 203 of the UMRA a small government agency plan. The plan must

provide for notifying potentially affected small governments, enabling

officials of affected small governments to have meaningful and timely

input in the development of EPA regulatory proposals with significant

Federal intergovernmental mandates, and informing, educating, and

advising small governments on compliance with the regulatory

requirements.

EPA has determined that this rule does not contain a Federal

mandate that may result in expenditures of $100 million or more for

State, local, and tribal governments, in the aggregate, or the private

sector in any one year. EPA has further determined that this rule

contains no regulatory requirements that might significantly or

uniquely affect small governments. This rulemaking should have minimal

financial impact, if any, on the current regulatory burden imposed on

regulated entities and regulators because the rulemaking does not

establish any additional regulatory requirements. The proposed rule

simply provides the option to modify approved methods or propose new

methods, if desired. EPA believes that method modifications and new

methods would not be used if not cost effective. Thus, today's rule is

not subject to the requirements of sections 202, 203, and 205 of the

UMRA.

C. Regulatory Flexibility Act

The Regulatory Flexibility Act, 5 U.S.C. 601 et seq., requires EPA

and other agencies to prepare a final regulatory flexibility analysis

for regulations that have a significant impact on a substantial number

of small entities. This regulatory action does not have any adverse

impact on either small or large entities. Therefore, a regulatory

flexibility analysis is not required. Pursuant to section 605(b) of the

Regulatory Flexibility Act, 5 U.S.C. 605(b), the Administrator

certifies that this rule will not have a significant economic impact on

a substantial number of small entities.

D. Paperwork Reduction Act

The information collection requirements in this proposed rule will

be submitted for approval to the Office of Management and Budget (OMB)

under the Paperwork Reduction Act, 44 U.S.C. 3501 et seq. shortly. EPA

is preparing an information collection request (ICR) document for this

proposed rule and will solicit public comment on it prior to

promulgating a final regulation. Comments on the proposed rule,

preamble, and ICR will all be considered before a final rule is

promulgated. The information collection requirements in this proposal

are described in Parts III.A (Method Flexibility), III.B (Quality

Control), III.C (Method Validation), III.D (Method Review), and III.E.6

(Standard Data Format). The information collection requirements in this

proposal are specified in Appendix E (Equivalency Checklists), Appendix

F (Guidelines and Format for Methods) and Appendix G (Method

Flexibility, Equivalency, and Approval) of 40 CFR part 136 and at 40

CFR 136.3(d); 136.4 (b) and (c); 136.5 (a), (b), (c), and (d); and at

40 CFR 141.27 (a), (b), and (c).

The information requirements are not effective until OMB approves

them. An Agency may not conduct or sponsor, and a person is not

required to respond to a collection of information unless it displays a

currently valid OMB control number. The OMB control numbers for EPA's

regulations are listed in 40 CFR part 9 and 48 CFR chapter 15.

V. Request for Comments

A. General

EPA is interested in eliciting constructive comments that would

allow the Agency to incorporate flexibility into existing methods and

to streamline the proposal and promulgation of new methods at 40 CFR

parts 136 and 141. On the other hand, EPA is interested in compelling

reasons why such a program may not work, even with extensive built-in

controls to ensure that the results produced by modified or new

analytical methods are reliable. EPA looks forward to working with all

interested and concerned parties to produce an improved system for

methods approval under the water methods program.

B. Specific

EPA is soliciting public comment on the following specific

questions and options that relate to technical and policy decisions

that EPA may need to make to implement the streamlining initiative.

1. As described in this preamble and the Streamlining Guide (EPA

1996a), the streamlining initiative would use a performance-based

approach in which a reference method that contains or is supplemented

with QC acceptance criteria is the standard against which a method

modification would be tested to demonstrate equivalency. In contrast to

the proposed performance-based reference-method approach, another

performance-based approach would be to specify only the QC acceptance

[[Page 14992]]

criteria without the need for a reference method. Should EPA retain the

proposed reference method approach with QC acceptance criteria? Or

should EPA change to a QC acceptance criteria approach only?

2. Regarding question number one above, for what analytes, methods

or monitoring situations, if any, do you believe EPA should allow use

of either the performance-based reference method approach or the QC

acceptance criteria only approach?

3. It may not be appropriate to develop QC acceptance criteria to

allow modification of methods for ``method-defined parameters,'' such

as biochemical oxygen demand or total suspended solids. What chemical,

microbiological, or biological analytes or analytical procedures do you

believe might not be amenable to streamlining or method flexibility

procedures?

4. Should EPA implement streamlining and method flexibility

procedures only for new regulatory actions? Should EPA apply these

procedures to existing regulatory requirements but only when these

requirements are updated for some other purpose? Or should EPA apply

these proposed procedures to existing regulations now?

5. EPA has undertaken several pilot studies of new methods to test

the streamlined method approval process, and expects the pilots to be

completed prior to promulgation of a final rule. Should EPA conduct

more extensive pilot studies, e.g., several pilots at each tier, or

should the changeover take place as soon as possible? If a pilot or

phase-in approach is adopted, should EPA phase-in by analyte group

(e.g., VOCs, metals, pesticides)? Or by the technologies employed by

the reference method (electron capture, mass spectrometry)?

6. Is the proposed flexibility to modify the front-end and

determinative steps in a reference method broad enough to be of value

to the methods development community? For what steps in a reference

method, if any, would you increase or decrease the flexibility to

modify a method? If method flexibility were broadened, what additional

standardized QC elements or checklist items should be added to ensure

and document acceptable performance of the modification?

7. If you believe that the proposed flexibility is too broad for

some methods, would you prefer that EPA limit flexibility by revising

approved methods to indicate the steps that could or could not be

changed? If yes, for which steps in a method (e.g., extraction/

digestion, concentration, determinative) or for which types of method

(e.g., those with method-defined analytes) should changes be allowed or

prohibited? If possible, please cite methods listed in 40 CFR part 136

or 141 as examples.

8. If method flexibility were implemented as proposed, are the

standardized QC elements (accuracy, precision, detection limit,

calibration, reference sample, matrix spikes, etc.) described in part

III.C of this proposal and in the Streamlining Guide (EPA 1996a)

adequate to validate the acceptability of a modification to a reference

method? If not, which QC elements should be added? On the other hand,

are the QC elements too extensive? If yes, which QC elements should be

deleted? And why?

9. There has been some concern about the effect that changes to the

chemistry of a method may have on a laboratory or method developer's

ability to validate the performance of a modified method using the

Checklists and other requirements in the Streamlining Guide (EPA

1996a). For example, what effect, if any, might changing the extraction

solvent have on extract holding times that would not be picked up by

the Checklists' criteria? What effect, if any, might use of a different

extraction technique or a different solvent-to-sample ratio have that

would not be picked up by the standardized QC? What, if any, QC

elements should be changed or added to mitigate these concerns?

10. Once EPA adopts streamlining and method flexibility procedures,

should EPA continue to develop and publish new methods or should EPA

rely on the private sector and consensus standards organizations? In

addressing this question, please consider the effect on small

laboratories, PWSs, and POTWs, if EPA discontinued providing EPA

methods.

11. EPA has determined that, for wastewater programs, a modified

method, once validated and documented in accordance with the details in

this proposal, would carry the same force and legal effect as a

reference method. Do stakeholders believe that a modified method should

have equal status with a reference method? Or should EPA require

different levels of documentation for data gathered with the modified

method? If a modified method had a different level of documentation,

would stakeholders accept that it has legal status equal to that of an

unmodified method?

12. Should EPA change the QC acceptance criteria in a reference

method when a significant technological advance or some other factor

demonstrates that the criteria could be made more rigorous? In your

response, you may assume that changing the criteria would not adversely

decrease the number of qualified laboratories needed to conduct

compliance monitoring with the more rigorous method.

13. EPA plans to implement streamlining and method flexibility for

water methods through informal gathering of public comment and through

rulemaking (Federal Register proposal, public comment, and final rule),

of which this proposal is a part. Are there additional measures needed

to ensure that all stakeholders would be aware of the initiative and,

if so, what additional steps should EPA take?

14. Given that a laboratory would be able to modify a method

without prior EPA approval, how would current EPA and state laboratory

auditing and certification programs continue to ensure that the

regulated community is properly conducting monitoring activities and

documenting monitoring system performance? Should documentation be

retained at the testing laboratory? At the facility? Or should EPA

require that the data be submitted to EPA or other regulatory authority

with each data package that results from use of the modification?

15. Adoption of streamlining and method flexibility procedures

would require a deeper understanding of the science behind measurement

methods. Consequently, ``first-line'' compliance and enforcement

efforts may require additional resources and training of auditors. What

training would EPA, the Regions, the States, laboratories, and the

regulated community need to employ to successfully implement

streamlining or method flexibility procedures? What courses could be

developed, and who should be responsible for their development?

16. Under the streamlining initiative, requests for approval of new

methods (i.e., new technologies or determinative techniques) would be

submitted to EPA under a streamlined ATP-type program. Should EPA

process these requests in the order received or should EPA have the

discretion to accelerate review of methods that provide the most

benefit to the Agency's regulatory program and/or to the needs of the

regulated community?

17. What additional steps, if any, should the Agency take to ensure

that the use of method flexibility does not compromise enforceability

of applicable statutes and regulatory requirements? Will additional

training be sufficient or will inspectors need additional

qualifications to be able to assess the

[[Page 14993]]

quality of CWA and SDWA compliance data produced by a modified or new

reference method? What resources would be required to mitigate concerns

about the need for appropriate training of inspectors?

18. EPA proposes to define several administrative (e.g., Assistant

Administrator, AMS Director) and technical (e.g. screening method,

standardized quality control) terms in the definitions at 40 CFR 136.2

and 141.2 and invites public comment on these definitions. Should EPA

omit any of the proposed definitions to avoid unnecessary confusion or

restrictions? Are there additional terms or concepts for which a

regulatory definition would be useful in implementing and administering

EPA's proposed methods approval system?

19. EPA invites public comment on the guidance contained in the

Streamlining Guide (EPA 1996a) and in Method Guidelines and Format (EPA

1996c). These documents, which are part of the administrative record

for this proposal, provide guidance on method flexibility and method

validation procedures under the proposed streamlining initiative. The

documents also provide examples of certification statements and

checklists that would satisfy EPA's proposed requirements for

documenting the performance and equivalency of a modified or new

method. Portions of these documents are proposed to be regulatory

requirements (for example, see the proposed Appendixes E, F, and G and

other amendments to 40 CFR parts 136 and 141). Which, if any, of the

proposed requirements should EPA remove from the regulations and only

keep as guidance?

20. In future rulemakings, EPA may propose to make more of the

information in the two documents described above regulatory

requirements. EPA would accomplish this by amending the wastewater and

drinking water regulations or, with the approval of the Office of the

Federal Register, incorporate by reference all or parts of the

Streamlining Guide (EPA 1996a) and Method Guidelines and Format (EPA

1996c) into the CFR. What, if any, additional guidance from these

documents should EPA propose as a regulatory requirement?

VI. References

APHA. 1995. Nineteenth edition of Standard Methods for

the Examination of Water and Wastewater, 1992, American Public

Health Association, 1015 Fifteenth Street NW, Washington, D.C.

20005.

ASTM. 1996. Annual Book of ASTM Methods, 1996, Vol.

11.01 and 11.02, American Society for Testing and Materials, 101

Barr Harbor Drive, West Conshohocken, PA 19428.

EPA. 1995a. Protocol for Alternate Test Procedures for

Coliform Bacteria in Compliance with Drinking Water Regulations:

Presence/Absence Liquid Culture Methods for Finished Waters, Ver.

1.2, December 1995, U.S. Environmental Protection Agency.

EPA. 1995b. Protocol for Alternate Test Procedures for

Coliform Bacteria in Compliance with Drinking Water Regulations:

Presence/Absence Membrane Filter Methods for Finished Waters, Ver.

1.2, December 1995, U.S. Environmental Protection Agency.

EPA. 1995c. Methods for the Determination of Organic

Compounds in Drinking Water--Supplement III, EPA-600/R-95-131,

August 1995, NTIS PB95-261616.

EPA. 1996a. Guide to Method Flexibility and Approval of

EPA Water Methods, December 1996 Draft, EPA-821-D-96-004, NTIS PB97-

117766, ERIC D-A43/D-A46 (Streamlining Guide, EPA 1996a).

EPA. 1996b. Methods for Organic Chemical Analysis of

Municipal and Industrial Wastewater, December 1996, EPA-821-B-96-

005, NTIS PB97-125298, ERIC D-A44/D-A47 (Organic Methods, EPA

1996b).

EPA. 1996c. Guidelines and Format for Methods to Be

Proposed at 40 CFR Part 136 or Part 141, EPA-821-B-96-003, NTIS

PB96-210448, ERIC D-A42/D-A45, July 1996 (Method Guidelines and

Format, EPA 1996c).

EPA. 1996d. Draft Memorandum from Assistant

Administrators, ``Implementation Plan for the Agency Performance-

Based Measurement System,'' October 25, 1996, U.S. Environmental

Protection Agency.

EPA. 1996e. Memorandum from Robert Perciasepe,

``Agency-wide Adoption of the Performance-Based Measurement System

Approach,'' November 1, 1996, U.S. Environmental Protection Agency.

List of Subjects

40 CFR Part 136

Environmental protection, Laboratories, Water pollution control,

Reporting and recordkeeping requirements.

40 CFR Part 141

Environmental protection, Laboratories, Water supply, Reporting and

recordkeeping requirements.

Dated: March 17, 1997.

Carol M. Browner,

Administrator.

For the reasons set out in the preamble, title 40 of the Code of

Federal Regulations is proposed to be amended as set forth below:

PART 136--GUIDELINES ESTABLISHING TEST PROCEDURES FOR THE ANALYSIS

OF POLLUTANTS

1. The authority for part 136 is proposed to be revised to read as

follows:

Authority: Secs. 301, 304(h), 307, and 501(a), Pub. L. 95-217,

91 Stat. 1566, et seq. (33 U.S.C. 1251, et seq.).

* * * * *

2. Section 136.2 is proposed to be revised to read as follows:

Sec. 136.2 Definitions.

As used in this part, the term:

Accuracy means the degree of agreement between an observed value

and an accepted reference value. Accuracy includes random error

(precision) and systematic error (bias) that are caused by sampling and

analysis.

Act means the Clean Water Act.

Administrator means the Administrator of the U.S. Environmental

Protection Agency (EPA).

Analyte or Analyte of concern means a substance or property that is

to be measured by an analysis.

Approved method means a testing procedure or analytical method

promulgated at this part or at 40 CFR parts 405 through 500.

Assistant Administrator (AA) means the EPA Assistant Administrator

for Water.

Calibration (CAL) means the process of establishing the

relationship between the concentration or amount of material introduced

into an instrument or measurement process and the output signal.

Calibration linearity means the degree to which calibration points

lie along a straight line.

Calibration verification means the means of establishing that

instrument performance remains within pre-established limits.

Determinative technique means the process (physical or chemical or

both) to measure the identity and concentration of an analyte. In test

methods, the determinative technique follows the front-end techniques.

Director means the Director of the State Agency authorized to carry

out an approved National Pollutant Discharge Elimination System Program

under section 402 of the Act.

Front-end technique means any technique in the analytical process

that precedes the determinative technique, including all procedures,

equipment, solvents, etc. that are used in the laboratory in the

preparation and cleanup of a sample but this excludes conditions and/or

procedures for the collection, preservation, shipment and storage of

the sample.

Initial precision and recovery test (IPR) means analysis of a

minimum of four spiked replicate reference matrix samples under the

same conditions as

[[Page 14994]]

will be used for analysis of environmental samples. The IPR is used to

demonstrate that a laboratory is able to produce reliable results with

the method prior to analysis of environmental samples.

Interference means a positive or negative effect on a measurement

caused by a substance other than the analyte being determined.

Matrix means the component or substrate that contains the target

analyte.

Matrix spike (MS) means a sample prepared by adding a known

quantity of target analyte to a specified amount of a sample matrix for

which an independent estimate of target analyte concentration is

available.

Matrix spike duplicate (MSD) means a duplicate of the matrix spike.

The MS/MSD are used in combination to test the precision of an

analysis.

Matrix type means a sample medium with common characteristics

across a given industrial category or industrial subcategory. Examples

include: C-stage effluents from chlorine bleach mills in the Pulp,

Paper, and Paperboard industrial category; effluent from the continuous

casting subcategory of the Iron and Steel industrial category; publicly

owned treatment work (POTW) sludge; and in-process streams in the

Atlantic and Gulf Coast Hand-shucked Oyster Processing subcategory.

Medium means the physical phase of a sample matrix. Air, water,

soil, sediment, rock, and sludge are sample media.

Method means an orderly and systematic arrangement of procedures

and techniques for performing an analysis.

Method blank (or blank) means a sample absent the analytes of

interest and interferences, which is processed through all steps of a

method simultaneously with and under the same conditions as samples

that may contain an analyte of interest.

Method detection limit (MDL) means the minimum concentration of a

substance that can be measured and reported with 99% confidence that

the analyte concentration is greater than zero as determined by the

procedure set forth in appendix B of this part.

Method Guidelines and Format means the procedures set forth in

appendix F of this part.

Method modification means a change to a reference method. The

change may be to a front-end technique or to the determinative

technique.

Method validation means a process by which a laboratory or vendor

establishes the performance of a new method or substantiates the

performance of a method modification.

Minimum level (ML) means the lowest level at which an entire

analytical system gives a recognizable signal and acceptable

calibration point for an analyte. It is equivalent to the concentration

of the lowest calibration standard, assuming that all method-specified

sample weights, volumes, and clean-up procedures have been employed.

National Pollutant Discharge Elimination System (NPDES) means the

national system for the issuance of permits under section 402 of the

Clean Water Act and includes any State or interstate program which has

been approved by the Administrator, in whole or in part, pursuant to

section 402 of the Clean Water Act.

New method means a combination of analyte of concern and

determinative technique that is different from those in the approved

methods.

Ongoing precision and recovery sample (OPR) means a spiked

reference matrix sample that is processed through all steps of a method

simultaneously with and under the same conditions as samples that may

contain an analyte of interest. Also called a laboratory control sample

(LCS), the OPR/LCS is used to demonstrate that a laboratory is able to

produce reliable results continuously.

Organic Methods means the document titled: Methods for the

Determination of Organic Compounds in Drinking Water--Supplement III

(available from the National Technical Information Service (NTIS), U.S.

Department of Commerce, Springfield, Virginia, 22161, 703/487-4600, at

NTIS publication PB97-125298).

Other approved method means a promulgated method that is not

designated as a reference method.

Percent recovery means the recovery multiplied by one hundred.

Person means an individual; corporation; company; association;

partnership; municipality; or State, Federal, or tribal agency.

Precision means the degree to which a set of observations or

measurements of the same property, usually obtained under similar

conditions, conform. Precision is usually expressed as standard

deviation, variance, or range, in either absolute or relative terms.

Preparation means processing performed on a sample prior to

analysis, including extraction, concentration, and cleanup.

Procedure means a set of systematic instructions for performing an

activity.

Promulgated method means a method that has been published or

incorporated by reference into 40 CFR parts 136 or 405 through 500.

Quality assurance (QA) means an integrated system of activities

involving planning, quality control, quality assessment, reporting, and

quality improvement to ensure that a product or service meets defined

standards of quality with a stated level of confidence.

Quality control (QC) means the overall system of technical

activities conducted to measure and control the quality of a product or

service so that it meets the needs of a user. The purpose of QC is to

provide quality that is satisfactory, adequate, dependable, and

economical.

Quality control acceptance criteria (QC acceptance criteria) means

performance specifications developed from validation data and used to

control the limits within which an analytical method is operated.

Recovery means the total amount of analyte found divided by the

amount of analyte added as a spike.

Reference method means an approved method that is designated as a

standard to which a modified method can be compared. A reference method

includes standardized QC and QC acceptance criteria as well as sample

preparation, cleanup, and other procedures.

Regional Administrator means an EPA Regional Administrator.

Screening method means a method that employs a qualitative

determinative technique for an analyte of interest that is different

from the determinative techniques used in the approved methods for that

analyte. The screening method should produce a false negative

probability less than 1%.

Selectivity means the capability of a method or instrument to

respond to an analyte in the presence of interferences.

Sensitivity means the capability of a method or instrument to

differentiate between different amounts or concentrations of an

analyte.

Spike means the process of adding a known amount of an analyte to a

sample to determine the recovery.

Spike amount means a known quantity of analyte added to a sample

and used to determine the recovery of a method.

Standard deviation means the measure of the dispersion of observed

values expressed as the positive square root of the sum of the squares

of the difference between the individual values of a set and the

arithmetic mean of the set, divided by one less than the number of

values in the set.

Standardized quality control (standardized QC) means a uniform set

of performance testing procedures that ensure reliable results.

Depending on

[[Page 14995]]

the method, standardized QC procedures include, but are not limited to,

the following: calibration, calibration linearity, calibration

verification, absolute retention time, absolute and relative retention

time precision, initial precision and recovery, ongoing precision and

recovery (laboratory control sample), surrogate or labeled compound

recovery, analysis of blanks, matrix spike and matrix spike duplicate

recovery and precision, demonstration of method detection limit(s), and

analysis of a reference sample.

Surrogate means a substance with properties that mimic the behavior

of an analyte, that is unlikely to be found in an environmental sample,

and that is added to the sample for quality control purposes.

Tier 1 means the application of a new or modified method in a

single laboratory to one or more matrix types.

Tier 2 means the application of a new or modified method by all

laboratories to one or more matrix types within a single industrial

category or subcategory.

Tier 3 means the application of a new or modified method by all

laboratories to all matrix types in all industrial categories and

subcategories (nationwide use).

3. Section 136.3 is proposed to be amended by revising the last two

sentences and Tables IB, IC, and ID in paragraph (a); by adding Table

IF in paragraph (a); by revising paragraphs (c) and (d); and by

removing paragraph (e) (Table II following paragraph (e) is unchanged)

to read as follows:

Sec. 136.3 Identification of test procedures.

* * * * *

(a) * * *

The discharge parameter values for which reports are required must

be determined by one of the standard analytical test procedures

incorporated by reference and described in Tables IA, IB, IC, ID, and

IE, or by any alternate test procedure which has been approved by the

Administrator or Assistant Administrator under the provisions of

paragraph (d) of this section and Secs. 136.4 and 136.5. Under

paragraphs (b), (c) of this section and 40 CFR 401.13 alternate test

procedures may be used when such other test procedures have been

previously approved by the Administrator, Assistant Administrator, or

Regional Administrator of the Region in which the discharge will occur,

and providing the Director of the State in which such discharge will

occur does not object to the use of such alternate test procedure.

Standardized QC and QC acceptance criteria for modifications of the

inorganic contaminant reference methods in Table IB are specified in

Table IF.

* * * * *

Table IB.--List of Approved Inorganic Test Procedures

--------------------------------------------------------------------------------------------------------------------------------------------------------

Other approved methods

Reference -----------------------------------------------------------------------------------------------------------

Parameter/methodology method 1, Standard methods 18th

35 Ed.39 ASTM 39 USGS 2, 39 AOAC--Intl.39 Other

--------------------------------------------------------------------------------------------------------------------------------------------------------

1. Acidity, as CaCO3, mg/L:

Electrometric endpoint or 305.1 2310 B(4a) D1067-92 ................. ................. .................

phenolphthalein endpoint.

2. Alkalinity, as CaCO3, mg/L:

Electrometric or 310.1 2320 B D1067-92 I-1030-85 973.43 3 .................

Colorimetric titration to 310.2 I-2030-85

pH 4.5, manual or

automated.

3. Aluminum--Total,4 mg/L;

Digestion 4 followed by:

AA direct aspiration 36.... 202.1 3111 D ...................... I-3051-85 ................. .................

AA furnace................. 202.2 3113 B ...................... ................. ................. .................

Inductively Coupled Plasma/ 5 200.7 3120 B ...................... ................. ................. .................

Atomic Emission

Spectrometry (ICP/AES).36.

Direct Current Plasma (DCP) ........... ......................... D4190-82(88) ................. ................. AES0029 34

36.

Colorimetric (Eriochrome ........... 3500-AI D ...................... ................. ................. .................

cyanine R).

4. Ammonia (as N), mg/L:

Manual, distillation (at pH 350.2 4500-NH3 B ...................... ................. 973.49 3 .................

9.5) 6 followed by:.

Nesslerization............. 350.2 4500-NH3 C D1426-93(A) I-3520-85 973.49 3 .................

Titration.................. 350.2 4500-NH3 E ...................... ................. ................. .................

Electrode.................. 350.3 4500-NH3 F or G D1426-93(B) ................. ................. .................

Automated phenate.......... 350.1 4500-NH3 H ...................... I-4523-85 ................. .................

Automated electrode........ ........... ......................... ...................... ................. ................. 379-75WE 7

5. Antimony--Total,4 mg/L;

Digestion 4 followed by:

AA direct aspiration 36.... 204.1 3111 B ...................... ................. ................. .................

AA furnace................. 204.2 3113 B ...................... ................. ................. .................

ICP/AES 36................. 5 200.7 3120 B ...................... ................. ................. .................

6. Arsenic--Total,4 mg/L:

Digestion 4 followed by.... 206.5 ......................... ...................... ................. ................. .................

AA gaseous hydride......... 206.3 3114 B 4.d D2972-93(B) I-3062-85 ................. .................

AA furnace................. 206.2 3113 B D2972-93(C) ................. ................. .................

ICP/AES 36................. 5 200.7 3120 B ...................... ................. ................. .................

Colorimetric (SDDC)........ 206.4 3500-As C D2972-93(A) I-3060-85 ................. .................

7. Barium--Total,4 mg/L;

Digestion 4 followed by:

AA direct aspiration 36.... 208.1 3111 D ...................... I-3084-85 ................. .................

AA furnace................. 208.2 3113 B D4382-91 ................. ................. .................

ICP/AES 36 ................ 5 200.7 3120 B ...................... ................. ................. .................

DCP 36..................... ........... ......................... ...................... ................. ................. AES0029 34

8. Beryllium--Total,4 mg/L;

Digestion 4 followed by:

[[Page 14996]]

AA direct aspiration....... 210.1 3111 D D3645-93(88)(A) I-3095-85 ................. .................

AA furnace................. 210.2 3113 B D3645-93(88)(B) ................. ................. .................

ICP/AES.................... 5 200.7 3120 B ...................... ................. ................. .................

DCP........................ ........... ......................... D4190-82(88) ................. ................. AES0029 34

Colorimetric (aluminon).... ........... 3500-Be D ...................... ................. ................. .................

9. Biochemical oxygen demand

(BOD5), mg/L:

Dissolved Oxygen Depletion. 405.1 5210 B ...................... I-1578-78 8 973.44 3 p. 17 9

10. Boron 37--Total, mg/L:

Colorimetric (curcumin).... 212.3 4500-B B ...................... I-3112-85 ................. .................

ICP/AES.................... 5 200.7 3120 B ...................... ................. ................. .................

DCP........................ ........... ......................... D4190-82(88) ................. ................. AES0029 34

11. Bromide, mg/L:

Titrimetric................ 320.1 ......................... D1246-82(88)(C) I-1125-85 ................. p. S44 10

12. Cadmium--Total,4 mg/L;

Digestion 4 followed by:

AA direct aspiration 36.... 213.1 3111 B or C D3557-90 I-3135-85 or 974.27 3 p. 37 9

(A or B) I-3136-85

AA furnace................. 213.2 3113 B D3557-90(C) ................. ................. .................

ICP/AES 36................. 5200.7 3120 B ...................... I-1472-85 ................. .................

DCP 36 .................... ........... ......................... D4190-82(88) ................. ................. AES0029 34

Voltametry 11.............. ........... ......................... D3557-90(C) ................. ................. .................

Colorimetric (Dithizone)... ........... 3500-Cd D ...................... ................. ................. .................

13. Calcium-Total,\4\ mg/L;

Digestion \4\ followed by:

AA direct aspiration....... 215.1 3111B 511-93(B) I-3152-85 ................. .................

ICP/AES.................... \5\ 200,7 3120 B ...................... ................. ................. .................

DCP........................ ........... ......................... ...................... ................. ................. AES0029 \34\

Titrimetric (EDTA)......... 215.2 3500-Ca D 511-93(A) ................. ................. .................

14. Carbonaceous biochemical

oxygen demand (CBOD5), mg/

L\12\:

Dissolved Oxygen Depletion ........... 5210B ...................... ................. ................. .................

with nitrification

inhibitor.

15. Chemical oxygen demand

(COD), mg/L; Titrimetric

410.1 5220 C D1252-88(A) I-3560-85 973.46 \3\ p. 17 \9\

410.2 ......................... ...................... I-3562-85 ................. .................

410.3 ......................... ...................... ................. ................. .................

Spectrophotometric, manual 410.4 5220 D D1252-88(B) I-3561-85 ................. Notes 13 or 14

or automated.

16. Chloride, mg/L:

Titrimetric (silver ........... 4500-Cl-B D512-89(B) I-1183-85 .................

nitrate).

(Mercuric nitrate)......... 325.3 4500-Cl-C D512-89(A) I-1184-85 973.51 \3\

Colorimetric, manual....... ........... ......................... ...................... I-1187-85 ................. .................

Automated (Ferricyanide)... 325.1 or 4500-Cl-E ...................... I-2187-85 ................. .................

325.2

17. Chlorine-Total residual, mg/

L; Titrimetric:

Amperometric direct........ 330.1 4500-Cl D D1253-86(92) ................. ................. .................

Iodometric direct.......... 330.3 4500-Cl B ...................... ................. ................. .................

Back titration ether end- 330.2 4500-Cl C ...................... ................. ................. .................

point \15\.

DPD-FAS.................... 330.4 4500-Cl F ...................... ................. ................. .................

Spectrophotometric, DPD.... 330.5 4500-Cl G ...................... ................. ................. .................

or Electrode............... ........... ......................... ...................... ................. ................. Note 16

18. Chromium VI dissolved, mg/

L; 0.45 micron filtration

followed by:

AA chelation-extraction.... 218.4 3111 C ...................... I-1232-85 ................. .................

Colorimetric ........... 3500-Cr D D1687-92(A) I-1230-85 ................. .................

(Diphenylcarbazide).

19. Chromium-Total,\4\ mg/L;

Digestion \4\ followed by:

AA direct aspiration \36\.. 218.1 3111 B D1687-92(B) I-3236-85 974.27 \3\ .................

AA chelation-extraction.... 218.3 3111 C ...................... ................. ................. .................

AA furnace................. 218.2 3113 B D1687-92(C) ................. ................. .................

ICP/AES \36\............... \5\ 200.7 3120 B ...................... ................. ................. .................

DCP \36\................... ........... ......................... D4190-82(88) ................. ................. AES0029 \34\

Colorimetric ........... 3500-Cr D ...................... ................. ................. .................

(Diphenylcarbazide).

[[Page 14997]]

20. Cobalt-Total,\4\ mg/L;

Digestion \4\ followed by:

AA direct aspiration....... 219.1 3111 B or C D3558-90(A or B) I-3239-85 ................. p. 37 \9\

AA furnace................. 219.2 3113 B D3558-90(C) ................. ................. .................

ICP/AES.................... \5\ 200.7 3120B ...................... ................. ................. .................

DCP........................ ........... ......................... D4190-82(88) ................. ................. AES0029 \34\

21. Color platinum cobalt units

or dominant wavelength, hue,

luminance purity:

Colorimetric (ADMI)........ 110.1 2120 E ...................... ................. ................. Note 18

(Platinum cobalt).......... 110.2 2120 B ...................... I-1250-85 ................. .................

Spectrophotometric......... 110.3 2120 C ...................... ................. ................. .................

22. Copper--Total,\4\ mg/L;

Digestion \4\ followed by:

AA direct aspiration \36\.. \5\ 220.1 3111 B or C D1688-90(A or B I-3270-85 or I- 974.27 \3\ p. 37 \9\

3271-85

AA furnace................. 220.2 3113 B D1688-90(C) ................. ................. .................

ICP/AES \36\............... \5\ 200.7 3120 B ...................... ................. ................. .................

DCP \36\................... ........... ......................... D4190-82(88) ................. ................. AES0029 \34\

Colorimetric (Neocuproine). ........... 3500-Cu D ...................... ................. ................. .................

(Bicinchoninate)........... ........... Or E ...................... ................. ................. 8506 \19\

23. Cyanide--Total, mg/L:

Manual distillation with ........... 4500-CN C D2036-91(A) ................. ................. .................

MgCl2 followed by.

Titrimetric................ ........... 4500-CN D ...................... ................. ................. p. 22 \9\

Spectrophotometric, manual. \31\335.2 4500-CN E D2036-91(A) I-3300-85 ................. .................

Automated \20\............. \31\335.3 ......................... ...................... ................. ................. .................

24. Cyanide amenable to

chlorination, mg/L:

Manual distillation with 335.1 4500-CN G D2036-91(B) ................. ................. .................

MgCl2 followed by

titrimetric or

Spectrophotometric.

25. Fluoride--Total, mg/L:

Manual distillation \6\ ........... 4500-F B ...................... ................. ................. .................

followed by.

Electrode, manual.......... 340.2 4500-F C D1179-93(B) ................. ................. .................

Automated.................. ........... ......................... ...................... I-4327-85 ................. .................

Colorimetric (SPADNS)...... 340.1 4500-F D D1179-93(A) ................. ................. .................

Automated complexone....... 340.3 4500-F E ...................... ................. ................. .................

26. Gold--Total,\4\ mg/L;

Digestion \4\ followed by:

AA direct aspiration....... 231.1 3111 B ...................... ................. ................. .................

AA furnace................. 231.2 ......................... ...................... ................. ................. .................

DCP........................ ........... ......................... ...................... ................. ................. AES0029 \34\

27. Hardness--Total, as CaCO3,

mg/L:

Automated colorimetric..... 130.1 ......................... ...................... ................. ................. .................

Titrimetric (EDTA), or Ca 130.2 2340 B or C D1126-86(92) I-1338-85 973.52B \3\ .................

plus Mg as their

carbonates, by inductively

coupled plasma or AA

direct aspiration. (See

Parameters 13 and 33)..

28. Hydrogen ion (pH), pH

units:

Electrometric measurement.. 150.1 4500-H+ B D1293-84(90) I-1586-85 973.41 \3\

(A or B)

Automated electrode........ ........... ......................... ...................... ................. ................. 378-75WA \21\

29. Iridium--Total,\4\ mg/L;

Digestion \4\ followed by:

AA direct aspiration....... 235.1 3111 B ...................... ................. ................. .................

AA furnace................. 235.2 ......................... ...................... ................. ................. .................

30. Iron--Total,\4\ mg/L;

Digestion \4\ followed by:

AA direct aspiration \36\.. 236.1 3111 B or C D1068-90 I-3381-85 974.27 \3\ .................

(A or B)

AA furnace................. 236.2 3113 B D1068-90(C) ................. ................. .................

ICP/AES \36\............... \5\ 200.7 3120 B ...................... ................. ................. .................

DCP \36\................... ........... ...

This text is long and has been trimmed here. Open the source document for the complete record.

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.